53 minutes ago @semodough
#ASCO23 - investor events really get going tomorrow $BMY $MRK $AZN $COGT $EFTR $DAWN $MRNA https://t.co/8DfU6BdQKJ
|
#AZN
#dawn
#mrna
#eftr
#azn
#tomorrow
|
8 hours ago @semodough
RT @OxAnalyst: $RCUS $GILD at #ASCO23
https://t.co/EwqbESSri1 https://t.co/g5FOHNEPEc
|
#GILD
#gild
#rcus
#rt
#GILD
|
8 hours ago @CatalystWatcher
RT @stock_titan: $GRCL Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refract…
|
#GRCL
#stock_titan
#refract
#gracell
#biotechnologies
#relapsed
|
8 hours ago @CatalystWatcher
$GRCL crushing it. https://t.co/O3PswetE1s
|
#GRCL
#crushing
#grcl
#GRCL
|
8 hours ago @CatalystWatcher
I think it's time to see $GRCL get the respect it deserves.
|
#GRCL
#deserves
#respect
#grcl
#catalystwatcher
#think
|
8 hours ago @CatalystWatcher
RT @JacobPlieth: Zero ICANS of any grade in $GRCL GC012F (FastCar manufactured CD19 x BCMA Car-T) trial in ~6L multiple myeloma #Asco23 htt…
|
#GRCL
#myeloma
#bcma
#jacobplieth
#fastcar
#manufactured
|
14 hours ago @semodough
RT @JacobPlieth: Lots of interest around this #Asco23 poster: $SGEN $PFE anti-ITGB6 ADC SGN-B6A. 23% ORR in head & neck, less impressive in…
|
#PFE
#sgen
#jacobplieth
#poster
#semodough
#anti
|
1 day ago @FlashAlert_me
$PTGX [15s. delayed] filed SEC form 4: Chief Development Officer Gupta Suneel:
Delivered securities 4,150 of Commo… https://t.co/kcsBTtpa5o
|
#PTGX
#suneel
#ptgx
#delivered
#delayed
#officer
|
1 day ago @biostocks
$JAZZ and $ZYME Present Positive Pivotal Phase 2b Trial Data at #ASCO23 Evaluating Zanidatamab in HER2-Amplified Bi… https://t.co/xnKnJ5AXCL
|
#JAZZ
#zyme
#zanidatamab
#jazz
#amplified
#pivotal
|
1 day ago @FlashAlert_me
$KALA [15s. delayed] filed SEC form 4: CHIEF EXECUTIVE OFFICER Iwicki Mark T:
Granted 71,715 of Common Stock at pr… https://t.co/7PKaXS2TpS
|
#KALA
#kala
#granted
#executive
#mark
#delayed
|
1 day ago @FlashAlert_me
$KALA [15s. delayed] filed SEC form 4: CHIEF FINANCIAL OFFICER Reumuth Mary:
Granted 14,736 of Common Stock at pri… https://t.co/Nj1paBtHLb
|
#KALA
#reumuth
#kala
#granted
#delayed
#officer
|
1 day ago @FlashAlert_me
$KALA [15s. delayed] filed SEC form 4: SEE REMARKS Trachtenberg Eric:
Granted 15,639 of Common Stock at price $0 o… https://t.co/hY5P9alV29
|
#KALA
#trachtenberg
#eric
#remarks
#kala
#granted
|
1 day ago @FlashAlert_me
$KALA [15s. delayed] filed SEC form 4: Director Blumenkranz Mark S.:
Disposed 73 of Common Stock and Granted of C… https://t.co/KJtkwYTidE
|
#KALA
#disposed
#kala
#granted
#director
#mark
|
1 day ago @FlashAlert_me
$KALA [15s. delayed] filed SEC form 4: SEE REMARKS Bazemore Todd:
Granted 21,158 of Common Stock at price $0 on 20… https://t.co/4jkxl64mmr
|
#KALA
#todd
#remarks
#kala
#granted
#delayed
|
1 day ago @FlashAlert_me
$KALA [15s. delayed] filed SEC form 4: Director PERRY GREGORY D:
Granted 1,738 of Common Stock at price $0 on 2023… https://t.co/QuGTckh5Jw
|
#KALA
#kala
#granted
#director
#delayed
#common
|
1 day ago @FlashAlert_me
$KALA [15s. delayed] filed SEC form 4: SEE REMARKS Brazzell Romulus K:
Granted 17,916 of Common Stock at price $0… https://t.co/848UxgCKNC
|
#KALA
#romulus
#remarks
#kala
#granted
#delayed
|
1 day ago @ACInvestorBlog
$OCEA loading up +!holding for the coming week.
|
#OCEA
#ocea
#acinvestorblog
#holding
#loading
#coming
|
1 day ago @CatalystWatcher
RT @PirateWaffle: $GRCL $3 break
|
#GRCL
#grcl
#GRCL
|
1 day ago @CatalystWatcher
$GRCL oral abstract for GC012F in RRMM at ASCO tomorrow. Expecting a PR. Company has yet to acknowledge or comment on updated data!
|
#GRCL
#rrmm
#abstract
#acknowledge
#oral
#grcl
|
1 day ago @CatalystWatcher
I have been talking about $GRCL a lot, but I do think they are on the verge of big pharma validation like $LVTX. Th… https://t.co/O6BMiZqVoT
|
#GRCL
#lvtx
#verge
#pharma
#grcl
#validation
|
1 day ago @FlashAlert_me
$ARQT [15s. delayed] filed SEC form 4: Director Curran Terrie:
Granted 4,375 of Common Stock at price $0 on 2023-0… https://t.co/wwDeaRVCFt
|
#ARQT
#wwdearvcftflashalert_me
#terrie
#curran
#arqt
#granted
|
1 day ago @FlashAlert_me
$ARQT [15s. delayed] filed SEC form 4: Director CHAUDHURI BHASKAR:
Granted 4,375 of Common Stock at price $0 on 20… https://t.co/AWfn4BR7fC
|
#ARQT
#arqt
#granted
#director
#delayed
#common
|
1 day ago @semodough
Mizuho $AXSM, Buy, $95.00 PT): Auvelity Tracker: Solid Week 32 Performance
|
#AXSM
#tracker
#auvelity
#axsm
#solid
#week
|
1 day ago @ACInvestorBlog
$OCEA still on my top watchlist following the $20 price target this week. Watching the break of $6
|
#OCEA
#ocea
#watchlist
#watching
#break
#following
|
1 day ago @ACInvestorBlog
$OCEA pulling back on very low volume. Breakout mode on hourly. Squeeze over 6.09 https://t.co/EfMXubcFpw
|
#OCEA
#efmxubcfpwacinvestorblog
#ocea
#mode
#hourly
#pulling
|
1 day ago @semodough
$EFTR will present data at #ASCO2023 on 6/4. $EFTR will host a conference call, also on 6/4 at 7PM EDT, to discuss… https://t.co/NeP7m4g7k2
|
#EFTR
#eftr
#host
#present
#discuss
#conference
|
2 days ago @unusual_whales
Carper bought heavy into Pfizer, $PFE, in 2020.
His returns on average in pharmaceuticals are close to 100%.
On 2… https://t.co/Rgwb6FUFOU
|
#PFE
#pfizer
#carper
#pharmaceuticals
#heavy
#returns
|
2 days ago @semodough
Stifel upgrading $FGEN to Buy $32 TP. FGEN is approaching critical data readouts for founding product, pamrevlumab… https://t.co/DEV8oQ6R8v
|
#FGEN
#fgen
#readouts
#upgrading
#founding
#approaching
|
2 days ago @biostocks
$FGEN upgraded to Buy at Stifel. PT $32
|
#FGEN
#fgen
#stifel
#upgraded
#FGEN
|
2 days ago @semodough
RT @ErikOtto2: Biotech Idea of the day: $ICVX. Icosavax is a low-profile vaccine player that has the potential for attractive long term app…
|
#ICVX
#icvx
#vaccine
#biotech
#semodough
#player
|
2 days ago @ACInvestorBlog
$OCEA awake
|
#OCEA
#ocea
#OCEA
|
2 days ago @ACInvestorBlog
$OCEA On the verge of a technical breakout https://t.co/9JsKM36x8S
|
#OCEA
#verge
#ocea
#technical
#breakout
#OCEA
|
2 days ago @ACInvestorBlog
$OCEA EOD run
|
#OCEA
#runacinvestorblog
#ocea
#OCEA
|
2 days ago @CatalystWatcher
After struggling since its $19 IPO in 2021, $GRCL on the verge of major a breakout/repricing. Dual oral presentatio… https://t.co/Md4NXgHDF3
|
#GRCL
#repricing
#verge
#oral
#dual
#grcl
|
2 days ago @semodough
JEFF $PTGX PT40 detailed Ph2b data july 4 supporting a competitive profile in psoriasis with a unique oral form,fur… https://t.co/6sgdVD6gA1
|
#PTGX
#ptgx
#oral
#detailed
#jeff
#july
|
2 days ago @biostocks
$PXMD Completes HAT-301 Registrational Trial for PAX-101.
HAT-301 is the Pivotal Efficacy Study to Support NDA Fili… https://t.co/BRMXkhDQSt
|
#PXMD
#registrational
#fili
#brmxkhdqstbiostocks
#pxmd
#efficacy
|
2 days ago @biostocks
$MTEM Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary Myeloma
|
#MTEM
#clinical
#extramedullary
#partial
#removal
#focuses
|
2 days ago @biostocks
$AZN announces discontinuation of the Brazikumab inflammatory bowel disease (IBD) development programme in Crohn’s… https://t.co/aftekR1ZQE
|
#AZN
#discontinuation
#crohn
#brazikumab
#bowel
#ibd
|
2 days ago @semodough
RT @Prof_Oak_: Upcoming events and expected moves from Cowen.
Should be an exciting June to wrap up Q2. Some confirmed events:
$MLTX IL-…
|
#MLTX
#events
#mltx
#cowen
#confirmed
#wrap
|
2 days ago @biostocks
$ANGN 1-for-10 Reverse Split
|
#ANGN
#angn
#splitbiostocks
#reverse
#ANGN
|
2 days ago @semodough
GUGG $AXSM From a commercial perspective, expect AXS-12 to be positioned as second line combo therapy with stimulan… https://t.co/rmcBiYl4Ry
|
#AXSM
#stimulan
#combo
#axsm
#therapy
#perspective
|
2 days ago @biostocks
$AXSM to Present New Sunosi Data at #SLEEP23
https://t.co/wdNojHG0MB
|
#AXSM
#sunosi
#axsm
#present
#co
#AXSM
|
2 days ago @OpenOutcrier
RT @majgeoinvesting: ???
*Citigroup raises target on $LXRX by 33% to $8.00 yesterday AM.
*Shares close up 14% to $3.40.
*Stock falls 20%…
|
#LXRX
#lxrx
#citigroup
#openoutcrier
#raises
#falls
|
2 days ago @biostocks
$LXRX prices $125M offering.
Public offering of 23.9M shares at $2.60/share + private placement of 24.1M shares at $2.60/share
|
#LXRX
#offering
#sharebiostocks
#placement
#lxrx
#private
|
2 days ago @semodough
RT @DrBioteck: @semodough $EFTR
All five responders had failed CDK4/6 blockade and fulvestrant, and Stifel estimated that zotatifin could…
|
#EFTR
#semodough
#zotatifin
#stifel
#fulvestrant
#drbioteck
|
2 days ago @semodough
$LPTX - BAIRD - has had some nice coverage on $LPTX - catalyst page been spot on https://t.co/vZufeApmm0 https://t.co/IPfTfZVxn3
|
#LPTX
#lptx
#baird
#spot
#page
#coverage
|
2 days ago @semodough
$LPTX Rapid enrollment for CRC definitely caught few eyes - maybe few funds - some interesting comments around the… https://t.co/BD7yrcFsHE
|
#LPTX
#lptx
#enrollment
#caught
#rapid
#eyes
|
2 days ago @biostocks
$REUN halt
|
#REUN
#haltbiostocks
#reun
#REUN
|
2 days ago @biostocks
$REUN Reunion Neuroscience Announces US$13.1M Take-Private Transaction with MPM BioImpact.
Reunion Shareholders to… https://t.co/qiwgfR2tYn
|
#REUN
#reunion
#neuroscience
#bioimpact
#reun
#transaction
|
3 days ago @semodough
$ASND Oncology R&D day focused on ph 1/2 results for TransCon IL-2 and TransCon TLR7/8.
IL-2 showed 35hr half-life,… https://t.co/mbCP0pi126
|
#ASND
#transcon
#oncology
#showed
#life
#half
|
3 days ago @biostocks
$BLTE Belite Bio 2M shares offering priced at $15/ADS. ? ? ?
|
#BLTE
#belite
#blte
#biostocks
#priced
#offering
|
3 days ago @semodough
RT @ErikOtto2: Biotech Idea of the day: $ICVX. Icosavax is a low-profile vaccine player that has the potential for attractive long term app…
|
#ICVX
#vaccine
#icosavax
#icvx
#player
#semodough
|
3 days ago @semodough
$GLPG Mid-23, Phase I CD19 CART data from the ATLANTA trial in rrNHL and the EUPLAGIA Phase I/IIa trial in rrCLL. (… https://t.co/T3K44nkCuG
|
#GLPG
#phase
#trial
#rrnhl
#rrcll
#glpg
|
3 days ago @ACInvestorBlog
$OCEA bottoming out on Hourly. https://t.co/IzzyCD3MMU
|
#OCEA
#hourly
#bottoming
#ocea
#OCEA
|
3 days ago @ACInvestorBlog
$OCEA Ocean Biomedical started at speculative buy with $20 stock price target at Taglich Brothers
|
#OCEA
#taglich
#speculative
#brothersacinvestorblog
#biomedical
#ocea
|
3 days ago @ACInvestorBlog
$OCEA getting some attention/volume
|
#OCEA
#volumeacinvestorblog
#ocea
#attention
#getting
#OCEA
|
3 days ago @ACInvestorBlog
$OCEA dont forget, the company is expected to be added to the Russell 2000® Index, effective after the U.S. market… https://t.co/Kxvi7DAztz
|
#OCEA
#forget
#russell
#dont
#ocea
#effective
|
3 days ago @ACInvestorBlog
$TRVN Trevena Announces Receipt of Milestone Payment From Partner in China Jiangsu Nhwa Pharmaceutical
|
#TRVN
#trvn
#trevena
#nhwa
#jiangsu
#receipt
|
3 days ago @semodough
$LPTX - interest continues- bigger name funds still acquiring???why is it esophagogastric, gynecologic, or colorect… https://t.co/F8u7w4YsIo
|
#LPTX
#lptx
#gynecologic
#colorect
#acquiring
#funds
|
3 days ago @FlashAlert_me
$VECT [15s. delayed]: Issued Press Release on May 31, 13:00:00: Moore Kuehn Encourages VECT, EMBK, BACK, and RADI I… https://t.co/D0z9szBx3V
|
#VECT
#vect
#moore
#kuehn
#radi
#embk
|
3 days ago @semodough
@Marc_J99 Listed $ICPT Pdufa in June not sure why. Not a fan
|
#ICPT
#icpt
#listed
#sure
#june
#ICPT
|
3 days ago @semodough
RT @Pharmdca: $EFTR Thread 1
Current market cap under 50 million offers an opportunity for investors looking for great risk reward in a sm…
|
#EFTR
#pharmdca
#thread
#semodough
#reward
#eftr
|
3 days ago @semodough
RT @mtheory11bio: $EFTR Tomivosertib (MNK inhibitor) had an ORR of 12% in NSCLC when combined with pembrolizumab after progressing on pembr…
|
#EFTR
#tomivosertib
#orr
#nsclc
#inhibitor
#semodough
|
3 days ago @semodough
$EFTR - 40-50 Mcap here - for distinct assets - Price has moved recently but was completely miss priced before -… https://t.co/F9m7DpFyBS
|
#EFTR
#mcap
#distinct
#completely
#eftr
#miss
|
3 days ago @semodough
@Pharmdca Agree @Pharmdca $EFTR data at #AACO23 had double orr at low dose 0.07. expect rp2d will be between 0.1-0… https://t.co/vcMdctE9Ti
|
#EFTR
#pharmdca
#dose
#eftr
#agree
#double
|
4 days ago @semodough
Exactly on $EFTR - 2 assets both active drugs - most investors unaware of both assets - $PFE https://t.co/IuGkmtSJeQ
|
#PFE
#assets
#unaware
#iugkmtsjeqsemodough
#drugs
#eftr
|
4 days ago @semodough
$ICVX consolidating nicely while waiting next catalyst very soon https://t.co/TeoeZRfg6X
|
#ICVX
#icvx
#consolidating
#nicely
#catalyst
#waiting
|
4 days ago @FlashAlert_me
$PHAT [15s. delayed] filed SEC form 4: Director Topper James N:
Granted 9,000 of Common Stock at price $0 on 2023-… https://t.co/FSfkiuvRxG
|
#PHAT
#topper
#fsfkiuvrxgflashalert_me
#james
#granted
#director
|
4 days ago @biostocks
$PFE Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial -
https://t.co/e3u9JngQ3S
|
#PFE
#pivotal
#phase
#trial
#positive
#announces
|
4 days ago @semodough
Stifel $FGEN Biotech Bus Tour Recap: High Confidence Going into IPF Trial
but Less Certain DMD Coming First
|
#FGEN
#firstsemodough
#fgen
#tour
#recap
#stifel
|
4 days ago @OpenOutcrier
$OCS (-3.4% pre) Oculis Holding (OCS) Announces Launch of Proposed Public Offering of Ordinary Shares - SI
https://t.co/rsqznxif9O
|
#OCS
#ordinary
#proposed
#launch
#holding
#public
|
4 days ago @ACInvestorBlog
$OCEA accumulation under $5
|
#OCEA
#ocea
#accumulation
#OCEA
|
4 days ago @ACInvestorBlog
$OCEA on my fireworks list.... just a matter of time.... https://t.co/lE2pS7fIVu
|
#OCEA
#fireworks
#ocea
#matter
#list
#time
|
4 days ago @OpenOutcrier
$LXRX (+19.5% pre) Lexicon Pharma (LXRX) Announces FDA Approval of INPEFA - SI
https://t.co/WPoKPi8kUp
|
#LXRX
#lxrx
#lexicon
#inpefa
#pharma
#approval
|
4 days ago @semodough
Chris - have you listened to $EFTR CEO here first 13 minutes - great overview on Zotatifin - not sure market giving… https://t.co/33FPJBKV8P
|
#EFTR
#zotatifin
#listened
#chris
#eftr
#overview
|
4 days ago @semodough
@Pharmdca appreciate your efforts putting $EFTR due diligence thread together - interesting comments from Stifel -… https://t.co/EGXGYva8Tt
|
#EFTR
#putting
#eftr
#stifel
#efforts
#together
|
4 days ago @biostocks
$BMY FDA Accepts for Priority Review NDA for Repotrectinib for the Treatment of Patients with Locally Advanced or M… https://t.co/ZRyyyXHFdU
|
#BMY
#zryyyxhfdubiostocks
#repotrectinib
#bmy
#priority
#patients
|
4 days ago @semodough
$AXSM Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Socie… https://t.co/Pffhj91s0K
|
#AXSM
#sunosi
#socie
#axsome
#axsm
#auvelity
|
4 days ago @semodough
RT @LifeSciFocus: $MREO NEEDHAM:
TIGIT Comeback? https://t.co/EYEViVyqkT
|
#MREO
#tigit
#eyevivyqktsemodough
#lifescifocus
#comeback
#co
|
4 days ago @FlashAlert_me
$CVAC [15s. delayed]: Issued Press Release on May 30, 07:30:00: CureVac Announces Financial Results for the First Q… https://t.co/8cDKaWmCIu
|
#CVAC
#curevac
#cvac
#delayed
#press
#issued
|
4 days ago @FlashAlert_me
$CVAC [15s. delayed, acc.~90%, always check] Earnings Release May 30, 07:30:00: Q1: Revenue $7.10M. https://t.co/W3qLA72lCd
|
#CVAC
#cvac
#delayed
#check
#always
#release
|
4 days ago @semodough
Stifel $EFTR PT 7 encouraged by larger sample size has corroborated early signals that zota triplet regimen is acti… https://t.co/sYHCaqZIgq
|
#EFTR
#zota
#triplet
#syhcaqzigqsemodough
#stifel
#acti
|
5 days ago @pennystocks
Palisade bio, PALI
|
#PALI
#shorting
#yesterday
#news
#back
#rinse
|
5 days ago @FlashAlert_me
$PHAT [15s. delayed]: Issued Press Release on May 29, 05:00:00: PHAT NEWS: The Klein Law Firm Initiates an Investig… https://t.co/RjW0nwTtv9
|
#PHAT
#phat
#investig
#klein
#initiates
#delayed
|
7 days ago @semodough
$OLMA interesting perhaps, company is hosting an investor event at the meeting (6/3 @8pm CT) which is likely to foc… https://t.co/SiD87p6VIg
|
#OLMA
#hosting
#perhaps
#meeting
#event
#interesting
|
7 days ago @semodough
$EFTR #ASCO23 abstracts that showed a 26% ORR (5 PR, n=19) from zotatifin in combination with fulvestrant &abemacic… https://t.co/4tmkUKIBM1
|
#EFTR
#fulvestrant
#abstracts
#abemacic
#zotatifin
#showed
|
8 days ago @HeroDividend
RT @huntdividends: ?3 Dividend Stocks Near 52 Week Lows- Buying Opportunity Or No??
1. $BMY (3.57% Yield) Dividend Safety score of 79 (Saf…
|
#BMY
#dividend
#huntdividends
#score
#lows
#safety
|
8 days ago @DilutionTracker
Daily Dilution Update 05/26
Offering
$TCRX $140m @ $2
$EFTR $7.5m RDO @ $0.655 w/ 100% wrt cov
$SBIG $4m @ $0.3
P… https://t.co/4vfQ5hmWIN
|
#EFTR
#tcrx
#sbig
#eftr
#rdo
#dilution
|
8 days ago @ACInvestorBlog
$OCEA im adding dips..... just waiting for another big pop..... Keep in mind, stock is expected to be added to the… https://t.co/X4HTU4UMsB
|
#OCEA
#dips
#im
#waiting
#mind
#adding
|
8 days ago @semodough
RT @buysidebio: New article on $GOSS- Bob Frantz saw the ole data & presented the prior ph.2 from $GOSS. Pay attention to quotes in article…
|
#GOSS
#goss
#article
#frantz
#quotes
#semodough
|
8 days ago @semodough
$EFTR nice data at #AACO23 double orr in these setting at low dose 0.07. Would expect rp2d will be between 0.1-0.14… https://t.co/1sPTKA4CUM
|
#EFTR
#dose
#eftr
#setting
#double
#expect
|
8 days ago @semodough
MIZUHO $EFTR #ASCO23 Abstract Positive Zotatifin Data,Investor Event June 4 BUY/$7 PT
$EFTR shares were strong (+6… https://t.co/fhHFMrS2cp
|
#EFTR
#eftr
#zotatifin
#abstract
#event
#positive
|
8 days ago @FlashAlert_me
$SLNO [15s. delayed] filed SEC form 4: 10% Owner PERCEPTIVE ADVISORS LLC:
Acquired 85,000 of 210859 at average pri… https://t.co/SrEh7LijjV
|
#SLNO
#slno
#owner
#advisors
#acquired
#delayed
|
8 days ago @semodough
Wish I paid more attention to $VSTM again
|
#VSTM
#againsemodough
#vstm
#wish
#paid
#attention
|
8 days ago @InvestorsLive
And there it goes $VSTM fast 20% rip they just baited everyone into weakness under $1 and made 'em pay. Standard pr… https://t.co/rP9BmVWAiT
|
#VSTM
#baited
#vstm
#pr
#standard
#weakness
|
8 days ago @InvestorsLive
$VSTM feels like they are trying to entice shorts into sub $1 while working out all the sellers. I'd be super cauti… https://t.co/MFRl9OFXLo
|
#VSTM
#entice
#cauti
#vstm
#sellers
#feels
|
8 days ago @semodough
TRUIST final ICER report is marginally positive for $MDGL resmetirom &more importantly for thyroid-beta agonist cla… https://t.co/IDgd26lpY7
|
#MDGL
#truist
#thyroid
#agonist
#beta
#importantly
|
8 days ago @semodough
RT @JD4for4: $NVCT NXP900 in xenograft model w/ YES1 gene amp resulted in -71% in tumor vol vs control vol growth +472% (p<0.001). NXP900 i…
|
#NVCT
#xenograft
#tumor
#nvct
#resulted
#gene
|
8 days ago @semodough
RT @CAMM29160: $NVCT ASCO abstract in esophageal squamous model: https://t.co/pfV2JiMVUn
|
#NVCT
#squamous
#esophageal
#nvct
#abstract
#asco
|
8 days ago @InvestorsLive
and they lived happily ever $EFTR
|
#EFTR
#eftrinvestorslive
#lived
#ever
#EFTR
|
8 days ago @InvestorsLive
$EFTR the end. https://t.co/X216uzdVFX
|
#EFTR
#eftr
#co
#EFTR
|
8 days ago @semodough
Baird $LPTX #ASCO23 Abstract Shows Strong OS of 19.5 Months in First-Line Gastric Cancer-first time, OS data from 2… https://t.co/GIk6WIi2Yo
|
#LPTX
#first
#gastric
#lptx
#baird
#abstract
|
9 days ago @FlashAlert_me
$ICVX [15s. delayed] filed SEC form 4: Chief Business Officer Cearley Cassia:
Disposed 10,000 of Common Stock at p… https://t.co/PbHQOc6GIB
|
#ICVX
#cearley
#cassia
#icvx
#disposed
#delayed
|
9 days ago @semodough
$ASND Ascendis reported initial data from the Ph1 dose-escalation of TransCon IL-2 β/γ +/- pembrolizumab in solid t… https://t.co/C6kZN7DABA
|
#ASND
#transcon
#asnd
#ascendis
#pembrolizumab
#escalation
|
9 days ago @biostocks
$TERN Announces Publication of TERN-701 Trial-in-Progress Abstract #ASCO23
https://t.co/FH2dK296GB
|
#TERN
#tern
#publication
#abstract
#progress
#trial
|
9 days ago @semodough
RT @OxAnalyst: $DAWN Clinical activity of pan-RAF inhibitor tovorafenib in the registrational pediatric low-grade glioma arm of the phase 2…
|
#DAWN
#tovorafenib
#inhibitor
#dawn
#registrational
#semodough
|
9 days ago @semodough
$DAWN new&updated clinical data from registrational FIREFLY-1 trial on June 4,2023 during an oral session from 12:0… https://t.co/aLZuJ5YWdu
|
#DAWN
#dawn
#registrational
#oral
#clinical
#trial
|
9 days ago @semodough
$DAWN - also will host investor event that night Day One will host a conference call and webcast on June 4, 2023, at 6:00 p.m. CT
|
#DAWN
#host
#ctsemodough
#dawn
#night
#event
|
9 days ago @semodough
duration of response (mDOR) of 37.0 months versus 15.7 months as of the last update. Also, for first time, $GRCL re… https://t.co/Wun9xmeGFw
|
#GRCL
#months
#duration
#grcl
#response
#versus
|
9 days ago @ACInvestorBlog
$OCEA adding some shares. The addition on Russell 2000 will force institutions to buy shares to readjust its portfolios.
|
#OCEA
#readjust
#russell
#portfolios
#institutions
#acinvestorblog
|
9 days ago @semodough
$LPTX 19.5 months median OS in overall first-line patient population, exceeding current benchmarks Long-term follow… https://t.co/WpRpzXJqW6
|
#LPTX
#lptx
#benchmarks
#population
#exceeding
#patient
|
9 days ago @biostocks
$VNDA Reports Results from a Phase 3 Study of Tradipitant in Motion Sickness
https://t.co/P45P8vLgwG
|
#VNDA
#vnda
#tradipitant
#sickness
#motion
#phase
|
9 days ago @semodough
RT @Quantumup1: Jefferies assumed $PTGX Buy⬆️PT $40 was $30
Rusfertide, a hepcidin mimetic, is in a Ph3 for polycythemia vera, w/ topline d…
|
#PTGX
#vera
#rusfertide
#ptgx
#topline
#jefferies
|
9 days ago @biostocks
$APLS study did not meet its primary endpoint of the Combined Assessment of Function and Survival (CAFS) rank score… https://t.co/mKJDbwMKO4
|
#APLS
#survival
#apls
#function
#endpoint
#score
|
9 days ago @InvestSpecial
Recently, BML played a key role with $MTCR. A classic busted biopharma going through an unfavorable reverse merger… https://t.co/JPEpMxTI0G
|
#MTCR
#mtcr
#unfavorable
#busted
#biopharma
#classic
|
9 days ago @semodough
RT @ej23ny: $MREO ? extremely bullish
setrusumab lead asset on $RARE pipeline could be value $2B+ but unfortunately currently no value…
|
#MREO
#value
#setrusumab
#mreo
#rare
#unfortunately
|
9 days ago @semodough
$APLS in ALS. #FAIL
|
#APLS
#failsemodough
#apls
#APLS
|
10 days ago @DilutionTracker
$SCLX Saddest part is the false hope all these div shares are giving the baggies.
Those shares may never see the… https://t.co/dAiqj4Uy72
|
#SCLX
#sclx
#saddest
#baggies
#giving
#false
|
10 days ago @OpenOutcrier
$CYTO (+33.7% pre) Altamira Therapeutics (CYTO) Reports Positive Top-Line Data from Bentrio Clinical Trial in Seaso… https://t.co/2uMKHHzbNB
|
#CYTO
#cyto
#seaso
#bentrio
#altamira
#therapeutics
|
10 days ago @semodough
$MDGL back to back days of $MDGL +10 On open. Volatility for sure https://t.co/tlcekqFMUs
|
#MDGL
#mdgl
#back
#tlcekqfmussemodough
#sure
#volatility
|
10 days ago @ACInvestorBlog
$CYTO took some at 91c for a swing trade
|
#CYTO
#tradeacinvestorblog
#swing
#cyto
#took
#CYTO
|
10 days ago @semodough
JP $PTGX CEO for a group discussion at the J.P. Morgan Biotech Corporate Mini Day in San Francisco yesterday. Hig… https://t.co/hO9sslipuH
|
#PTGX
#ptgx
#mini
#biotech
#morgan
#francisco
|
10 days ago @semodough
$PTGX nugget Reading b/w the lines,assume2113 to advance into next stage of development near- term for PsO, psoriat… https://t.co/Pdn3E5FMaU
|
#PTGX
#psoriat
#ptgx
#nugget
#reading
#advance
|
10 days ago @semodough
BAIRD $LPTX Initial data from Part A of the DeFianCe Study of DKN-01 In assessing the initial data, a ~20% response… https://t.co/ZU1eg6Eunw
|
#LPTX
#initial
#defiance
#assessing
#lptx
#baird
|
10 days ago @semodough
$ICVX - 6 month data came 12-14-22 so very likely $ICVX 12 month data around mid June https://t.co/L6kKgUECCm
|
#ICVX
#icvx
#month
#came
#june
#likely
|
10 days ago @OpenOutcrier
$PALI (+8.3% pre) Palisade Bio Inc. (PALI) LB1148 Two Ongoing Clinical Trials Expecting Topline Data Readouts - SI
https://t.co/r8ewjcAE3V
|
#PALI
#pali
#topline
#readouts
#trials
#expecting
|
10 days ago @InvestorsLive
After $UTRS have to watch $PALI since patents are hot running over 200%
Have to see if $PALI builds though don't… https://t.co/yLpATT7lUk
|
#PALI
#pali
#utrs
#patents
#builds
#running
|
10 days ago @semodough
$PALI - small biotech Mcap 12 million with data soon that’s FDA fast tract $PALI had news release today on upcoming… https://t.co/6u7VIxedWa
|
#PALI
#pali
#tract
#mcap
#biotech
#fast
|
10 days ago @InvestorsLive
$PALI tweet a few min ago (maybe gives a 2nd boost to the $1.58 idea on the patent posted earlier) https://t.co/xlJ9EhmdoZ
|
#PALI
#pali
#boost
#tweet
#patent
#posted
|
11 days ago @semodough
$ICVX next catalyst 12M follow-up for the RSV monovalent mid-2023
An older adult study will start mid-2023 (details… https://t.co/99rvLoArks
|
#ICVX
#adult
#icvx
#older
#catalyst
#study
|
11 days ago @biostocks
$PHAT 11.12M shares offering priced at $11.75/share
|
#PHAT
#sharebiostocks
#priced
#offering
#PHAT
|
11 days ago @unusual_whales
Carper bought heavy into Pfizer, $PFE, in 2020.
His returns on average in pharmaceuticals are close to 100%. On… https://t.co/zVffTr70vC
|
#PFE
#pfizer
#carper
#heavy
#returns
#bought
|
11 days ago @semodough
$LPTX Baird LPTX 2nd agent appears underappreciated not in stock https://t.co/8PEbvoJDdu over recent months from As… https://t.co/NfHErNCQgt
|
#LPTX
#lptx
#underappreciated
#agent
#baird
#appears
|
11 days ago @semodough
Very important nugget on $LPTX https://t.co/uhxLTPKH3w
|
#LPTX
#lptx
#important
#LPTX
|
11 days ago @semodough
@srqstockpicker $LPTX CRC Initial data from Part A of the DeFianCe Study of DKN-01 for the treatment of colorectal… https://t.co/xR6LYgQMjX
|
#LPTX
#srqstockpicker
#defiance
#lptx
#treatment
#study
|
11 days ago @InvestorsLive
I stopped $OCEA from circuit down into close on my cover, I apologize.
|
#OCEA
#circuit
#apologize
#stopped
#investorslive
#ocea
|
11 days ago @Albert_trades
$PLTR $CVNA $PFE $MRNA on my watchlist for tomorrow.
Can continue to ride the momentum names until things slow dow… https://t.co/PBYspmRFKr
|
#PFE
#slow
#pltr
#ride
#names
#tomorrow
|
11 days ago @ProfitsTaken
?Great job on $PFE today Brax!
Glad the new Insiders area is serving everyone well!
That's a ?ROI! Lots of very a… https://t.co/uXUHlny5m1
|
#PFE
#insiders
#glad
#lots
#serving
#area
|
11 days ago @ProfitsTaken
RT @GoatSnags: @ProfitsTaken thanks! for the 81% on $PFE
|
#PFE
#profitstaken
#thanks
#PFE
|
11 days ago @biostocks
$IMVT Credit Suisse reiterates Underperform.
PT $4?♂️
|
#IMVT
#reiterates
#underperform
#suisse
#imvt
#biostocks
|
11 days ago @ProfitsTaken
?Great job Nate! $PFE has been ? today #optionstrading interesting choice of calls! https://t.co/QYhuezrrmk
|
#PFE
#nate
#choice
#interesting
#calls
#great
|
11 days ago @ACInvestorBlog
$ZURA off $OCEA low float bio despac
|
#OCEA
#zura
#ocea
#float
#OCEA
|
11 days ago @semodough
BOFA $FGEN estimate Zeph1 DCF up/down +15-35% vs. -65%. maintain Buy on FGEN on favorable risk/benefit for upcoming Ph3 IPF readout mid-‘23.
|
#FGEN
#fgen
#readout
#bofa
#maintain
#semodough
|
11 days ago @semodough
Jeff $ICVX First-in-Class RSV/hMPV Vaccine Ph1 Data Hitting Our Bull Case BuyPT 30 see a good entry point to invest… https://t.co/3HMPypIEbo
|
#ICVX
#buypt
#vaccine
#jeff
#hmpv
#hitting
|
11 days ago @semodough
Cowen $ICVX IVX-A12 INDUCES RESPONSES AGAINST RSV+HMPV, NO EVIDENCE OF IMMUNE INTERFERENCE -Most encouraging, IVX-A… https://t.co/ftT8Dczw4a
|
#ICVX
#immune
#responses
#cowen
#hmpv
#encouraging
|
12 days ago @semodough
$MDGL June 22: Oral presentation of the Phase 3 MAESTRO-NASH at EASL $VKTX https://t.co/mT2Xkb4QXo
|
#MDGL
#vktx
#mdgl
#maestro
#easl
#nash
|
12 days ago @semodough
RBC - great read on $BLU $GSK buyout - & all that happened last couple years - unreal
|
#BLU
#unrealsemodough
#buyout
#read
#happened
#couple
|
12 days ago @semodough
Baml $BMY BMS-986278 showed solid efficacy with 62% relative reduction for the rate of change in ppFVC vs. placebo… https://t.co/rR5SueKflm
|
#BMY
#ppfvc
#baml
#placebo
#efficacy
#showed
|
12 days ago @semodough
@LifeSciFocus Best guess it’s always linked to $ICPT ????
|
#ICPT
#linked
#semodough
#icpt
#guess
#always
|
12 days ago @semodough
$ICVX Icosavax Announces Positive Topline Interim Phase 1 Results for Bivalent VLP Vaccine Candidate IVX-A12 Agains… https://t.co/w0R4JdOhp1
|
#ICVX
#agains
#vaccine
#bivalent
#ivx
#interim
|
12 days ago @semodough
$ICVX Concurrent $67.8 million registered direct offering; extends cash runway into 2H 2025 –. Imho would not be su… https://t.co/lUk3YNGDXT
|
#ICVX
#runway
#imho
#concurrent
#extends
#icvx
|
12 days ago @semodough
$ICVX IVX-A12 induced robust immune responses at Day 28 to both RSV and hMPV in older adults –
– IVX-A12 was gene… https://t.co/3dq9PR3c7q
|
#ICVX
#rsv
#immune
#responses
#hmpv
#adults
|
12 days ago @semodough
$ICVX had 200 million cash. This registered direct offering was obviously RA wanted more or another fund wanting in most likely
|
#ICVX
#wanting
#icvx
#wanted
#registered
#obviously
|
12 days ago @semodough
$ICVX looks like robust response GMFR at Day 28 was up to 5-fold in hMPV-A and 4-fold in hMPV-B. In a pre-specified… https://t.co/eRhSdnJRF5
|
#ICVX
#fold
#hmpv
#specified
#icvx
#response
|
12 days ago @semodough
$ICVX led by new investor TCGX with participation by additional new investors including Logos Capital and Vivo Capi… https://t.co/MdzxBVTysR
|
#ICVX
#mdzxbvtysrsemodough
#capi
#tcgx
#logos
#vivo
|
12 days ago @unusual_whales
At close: $PFE, $TSLA, $GOOGL, ???
Link: https://t.co/F4eY8aRYjU https://t.co/eZgrbsWROd
|
#PFE
#ezgrbswrodunusual_whales
#link
#googl
#close
#tsla
|
12 days ago @OpenOutcrier
$IMMX (+22.6% pre) Nexcella Announces Positive NXC-201 Clinical Results at ASGCT: 100% Overall Response Rate in DAR… https://t.co/d1ZEeoMKO7
|
#IMMX
#nexcella
#asgct
#response
#clinical
#overall
|
12 days ago @OpenOutcrier
$RDHL (+3.8% pre) RedHill Biopharma (RDHL) Provides R&D Update - SI
https://t.co/a6WuIcXRSG
|
#RDHL
#rdhl
#redhill
#biopharma
#provides
#update
|
12 days ago @semodough
Cantor $MLTX: STARTING SOON | Fireside Chat with MoonLake Management @ 12 ET
|
#MLTX
#moonlake
#etsemodough
#mltx
#fireside
#cantor
|
12 days ago @OpenOutcrier
$OCS (+3.6% pre) Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular… https://t.co/I7AIqJiqaF
|
#OCS
#oculis
#diamond
#macular
#diabetic
#stage
|
12 days ago @semodough
Piper $VECT head scratcher this isn't exactly premium or timing would have expected for a deal given proximity of a… https://t.co/2dIWzV8ANn
|
#VECT
#scratcher
#piper
#timing
#proximity
#head
|
12 days ago @biostocks
$ICPT downgraded to Sell at H.C.W. PT $8
|
#ICPT
#downgraded
#icpt
#sell
#ICPT
|
12 days ago @OpenOutcrier
$ICPT (-15.1% pre) Intercept shares tumble on concerns over NASH drug prospects - Reuters
https://t.co/H5lMhPz3kV
|
#ICPT
#tumble
#reuters
#prospects
#intercept
#concerns
|
12 days ago @TradeWithAlerts
Nice print for $PFE Size: 304126 Price: 36.86 Amount: $11,210,084.36 Time: 930
See more: https://t.co/9Zy8l0wcC6
Jo… https://t.co/pEtx5vfXLN
|
#PFE
#pfe
#print
#size
#amount
#nice
|
12 days ago @Couzin_Vinny
$PFE big pop shorts covering #news @MarketSmith @InvestorsBusinessDaily @IBDinvestors #IBDpartner… https://t.co/ibKdqpOZVl
|
#PFE
#marketsmith
#covering
#shorts
#news
#co
|
12 days ago @biostocks
$OCS Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with O… https://t.co/efshfhhQgF
|
#OCS
#oculis
#macular
#efshfhhqgfbiostocks
#edema
#diamond
|
12 days ago @semodough
RT @mtheory11bio: 1/ $MREO may be one of the most overlooked biotech companies as they have two potential blockbusters in their pipeline an…
|
#MREO
#mreo
#blockbusters
#overlooked
#pipeline
#semodough
|
12 days ago @FlashAlert_me
$PHAT [15s. delayed]: Issued Press Release on May 22, 07:05:00: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Phathom… https://t.co/UnDuS71Gvj
|
#PHAT
#phathom
#phat
#counsel
#rosen
#press
|
12 days ago @semodough
RT @jfais20: $LPTX (NP)
$85M MC @ 130M diluted shares, -$15M EV
$102M cash= at least 1.5 year runway
New LT data from 1L GEA trial at AS…
|
#LPTX
#lptx
#mc
#diluted
#runway
#semodough
|
12 days ago @FlashAlert_me
$RDHL [15s. delayed] filed form 6-K on May 22, 07:02:16 https://t.co/0C0VtEi8a4
|
#RDHL
#rdhl
#delayed
#form
#filed
#co
|
12 days ago @biostocks
$RDHL to terminate RHB-204's U.S. Phase 3 study for Non-tuberculosis Mycobacteria (NTM) disease due to low accrual… https://t.co/XChYb7plnF
|
#RDHL
#tuberculosis
#terminate
#mycobacteria
#accrual
#rdhl
|
12 days ago @FlashAlert_me
$IMVT [15s. delayed] filed form 10-K on May 22, 07:10:20 https://t.co/kCHTozT8lS
|
#IMVT
#imvt
#delayed
#form
#filed
#co
|
12 days ago @FlashAlert_me
$IMVT [15s. delayed] filed form 8-K on May 22, 07:03:03 https://t.co/XdTaQitMne
|
#IMVT
#xdtaqitmneflashalert_me
#imvt
#delayed
#form
#filed
|
12 days ago @biostocks
$ICPT to resume at 7.10 am ET
|
#ICPT
#resume
#etbiostocks
#icpt
#ICPT
|
12 days ago @biostocks
$ICPT resumes. ↓ 15%
|
#ICPT
#resumes
#biostocks
#icpt
#ICPT
|
12 days ago @semodough
RT @semodough: $VECT 221m cash -May 9, 2023 – Additional data from Phase II STARS-Nutrition study for apraglutide in
adult SBS-IF CIC
Q2 20…
|
#VECT
#semodough
#nutrition
#apraglutide
#stars
#adult
|
12 days ago @semodough
RT @semodough: LIFESCI $VECT (OUTPERFORM,$31.00 PT): Initiating Coverage: Other GLP-2s Come Up Short Against Apraglutide
|
#VECT
#apraglutidesemodough
#outperform
#coverage
#vect
#semodough
|
15 days ago @biostocks
$ICPT Announces Outcome of FDA AdComm for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH.… https://t.co/G1067BJSdk
|
#ICPT
#adcomm
#obeticholic
#fibrosis
#cirrhotic
#acid
|
15 days ago @semodough
$GOSS will be presenting data from TORREY at ATS on 5/22 (9:04am, Session B13) that will have a expansion of the da… https://t.co/BsxCeWqViJ
|
#GOSS
#torrey
#presenting
#bsxcewqvijsemodough
#da
#expansion
|
15 days ago @semodough
$NEXI yes one thing that I saw mgt team pretty experienced with meaningful years at $AZN $KITE $CELG $GILD - lates… https://t.co/jZ5vlfYMfi
|
#AZN
#celg
#meaningful
#kite
#gild
#nexi
|
15 days ago @CatalystWatcher
RT @PirateWaffle: $GRCL $2.30 … peanuts on this undervalued gem.
|
#GRCL
#peanuts
#piratewaffle
#catalystwatcher
#undervalued
#grcl
|
15 days ago @CatalystWatcher
RT @PirateWaffle: $GRCL Gorgeous https://t.co/P7sB7hY1p8
|
#GRCL
#piratewaffle
#grcl
#co
#GRCL
|
15 days ago @semodough
$ICPT safety - not even close to $MDGL $VKTX a reported so far $VKTX better then placebo in areas… https://t.co/6qMK2noYyL
|
#ICPT
#vktx
#placebo
#mdgl
#icpt
#safety
|
15 days ago @biostocks
$CVAC Announces Developments in Patent Litigation with $PFE $BNTX
https://t.co/mcH0IOrQ2H
|
#PFE
#cvac
#bntx
#patent
#litigation
#developments
|
15 days ago @semodough
RT @ej23ny: $MREO
Binary catalyst for the 2nd lead asset alvelestat in #AATD-LD indication
IMHO the Company is exploring potential par…
|
#MREO
#binary
#alvelestat
#aatd
#mreo
#exploring
|
15 days ago @semodough
RT @StephanKlingel1: $MREO great abstract @Pharmdca @PharmDabbler @PharmD_KS ? https://t.co/3XjgkB2His
|
#MREO
#pharmdabbler
#pharmd_ks
#abstract
#pharmdca
#mreo
|
15 days ago @semodough
RT @Pharmdca: $DAWN January updates
Three patients with confirmed complete responses, 59% (n=41) partial responses (31 confirmed and 10 u…
|
#DAWN
#responses
#confirmed
#dawn
#partial
#semodough
|
15 days ago @semodough
$AXSM KOL has now prescribed to 20 patients, up from six patients three months ago. KOL remarked that 60-70% of his… https://t.co/3e2kIVxXea
|
#AXSM
#patients
#remarked
#axsm
#ago
#three
|
15 days ago @FlashAlert_me
$CVAC [15s. delayed]: Issued Press Release on May 19, 07:15:00: CureVac Announces Developments in Patent Litigation… https://t.co/87fIACFnE2
|
#CVAC
#cvac
#curevac
#patent
#litigation
#developments
|
15 days ago @biostocks
$ICPT halt. AdComm
|
#ICPT
#adcommbiostocks
#icpt
#ICPT
|
15 days ago @FlashAlert_me
$ICPT [15s. delayed]: Issued Press Release on May 19, 07:05:00: Intercept Pharmaceuticals Stock Trading Halted Toda… https://t.co/RhvcWrpaGD
|
#ICPT
#toda
#rhvcwrpagdflashalert_me
#intercept
#halted
#pharmaceuticals
|
16 days ago @semodough
RT @Quantumup1: Raymond James $VKTX
vs $MDGL's pooled P2 12W doses, VK2809's fat reduction is greater
All of this@ doses multiples lower th…
|
#MDGL
#doses
#vktx
#pooled
#multiples
#mdgl
|
16 days ago @semodough
RT @BobMarshall63: $NVCT CEO Ron Bentsur open market purchase at $17.02 per share -- while small amount, note that his total ownership is n…
|
#NVCT
#nvct
#bentsur
#ownership
#semodough
#purchase
|
16 days ago @unusual_whales
The FDA has recommended full approval of Pfizer’s, $PFE, vaccine that protects infants from RSV, but it has also ra… https://t.co/a6pmNn7PJl
|
#PFE
#recommended
#protects
#infants
#approval
#vaccine
|
16 days ago @TradeWithAlerts
Nice print for $PFE Size: 373002 Price: 36.71 Amount: $13,692,903.42 Time: 930
See more: https://t.co/9Zy8l0wcC6
Jo… https://t.co/dPfeAM1We6
|
#PFE
#jo
#print
#amount
#size
#nice
|
16 days ago @biostocks
$FGEN Announces Positive Topline Results from China Pivotal Phase 3 Clinical Trial of Roxadustat for the Treatment… https://t.co/d9dGn5sILg
|
#FGEN
#topline
#roxadustat
#fgen
#pivotal
#treatment
|
16 days ago @semodough
$MREO All the shares purchased during 1st qtr by institutional investors https://t.co/c3R8tCOxfp https://t.co/Ydn82CUT3b
|
#MREO
#mreo
#institutional
#purchased
#MREO
|
16 days ago @semodough
$GRCL to present a clinical data update on GC012F's (FasTCAR-T BCMA/CD19) in relapsed-refractory multiple myeloma… https://t.co/fwlJNcGYde
|
#GRCL
#myeloma
#fwljncgydesemodough
#refractory
#fastcar
#relapsed
|
16 days ago @CatalystWatcher
$GRCL 178k block. The loading ahead of ASCO continues.
|
#GRCL
#loading
#catalystwatcher
#asco
#block
#grcl
|
16 days ago @semodough
RT @LifeSciFocus: $DAWN HCW: FIREFLY-1 ASCO Preview—Tovo’s the Total Package; Remain Bullish on Approval https://t.co/c6wAzoJsnh
|
#DAWN
#tovo
#package
#lifescifocus
#firefly
#dawn
|
17 days ago @semodough
$VKTX i understand not apples to apples but pretty close ?- was looking at $VKTX data more& more with $MDGL data -… https://t.co/FG6EMgDvmz
|
#MDGL
#vktx
#apples
#mdgl
#understand
#pretty
|
17 days ago @semodough
$AZN Phase III FLAURA2 study for Tagrisso in combination with chemotherapy hit primary PFS endpoint, demonstrating… https://t.co/cM3Lm9pvzZ
|
#AZN
#tagrisso
#chemotherapy
#endpoint
#demonstrating
#primary
|
17 days ago @ACInvestorBlog
$KALA setting up https://t.co/8GVrfdWtsV
|
#KALA
#setting
#KALA
|
17 days ago @semodough
RT @smantel: $ICVX $8.14. 28.8M float, > 2M short = 7.1% SI. $196M net cash good for 9+ qtrs @ current burn rate. 6 mo. RSV vaccine data be…
|
#ICVX
#vaccine
#qtrs
#smantel
#burn
#semodough
|
17 days ago @semodough
Baird $LPTX 1Q23 earnings were uneventful, continue to rate the stock Outperform PT 3 ahead of data from four clin… https://t.co/lz3T4MDiLa
|
#LPTX
#uneventful
#clin
#lptx
#baird
#outperform
|
17 days ago @semodough
@srqstockpicker HUMM - have to wonder if some DOC saw something ?? $LPTX - also wonder now if baker boys hearing something ???
|
#LPTX
#wonder
#something
#srqstockpicker
#baker
#lptx
|
17 days ago @semodough
@smantel $MREO - nice overall post on $MREO - lots of parts - lots to digest - been trying to point this out for aw… https://t.co/3EzZuJLZuZ
|
#MREO
#mreo
#lots
#smantel
#digest
#parts
|
17 days ago @semodough
RT @smantel: $MREO $1.29 Can buy now for 1/2 the ACB of largest s/h Rubric. Other high-profile s/h here. Many near-term catalysts. Rumors o…
|
#MREO
#rumors
#rubric
#smantel
#catalysts
#mreo
|
17 days ago @semodough
$MREO strong conviction by Rock Springs Capital CAPTIAL disclosed 1 qtr 13F holdings: continues to hold huge posit… https://t.co/91rd3O5sww
|
#MREO
#springs
#posit
#conviction
#rock
#mreo
|
17 days ago @semodough
@ej23ny I am paying attention to $MREO / especially what Rubric is doing - really liked there work on Setrusumab al… https://t.co/3X7bAnWa2Y
|
#MREO
#setrusumab
#rubric
#mreo
#especially
#attention
|
17 days ago @semodough
RT @JspDilution: $MREO over 1.30/1.35 this can be explosive
two abstracts at event ahead
Funds into 2026.
Big royalties https://t.co/pXQJ…
|
#MREO
#royalties
#jspdilution
#abstracts
#semodough
#mreo
|
17 days ago @semodough
$VKTX safety better then placebo - $ICPT drug not needed at all with $MDGL $VKTX much better options https://t.co/yYJkAXNA1k
|
#ICPT
#vktx
#better
#placebo
#mdgl
#icpt
|
17 days ago @FlashAlert_me
$BMEA [15s. delayed] filed SEC form 4: 10% Owner A2A Pharmaceuticals, Inc.:
Disposed 25,000 of Common Stock at pri… https://t.co/5pPTq1KMJF
|
#BMEA
#bmea
#owner
#pharmaceuticals
#common
#delayed
|
18 days ago @StockMarket
Found some news on PaxMedica that I wanted to Share
|
#PXMD
#paxmedica
#suramin
#treatment
#disorders
#autism
|
18 days ago @biostocks
$PFE Prices $31B Debt Offering.
Pfizer intends to use the net proceeds of the offering as part of the financing for… https://t.co/r2OGsDHa1l
|
#PFE
#offering
#pfizer
#proceeds
#financing
#part
|
18 days ago @semodough
safety profile also appears better than resmetirom, in that their Phase 2 GI AEs were 47% vs. 11% in the pbo group $VKTX $MDGL $TERN #NASH
|
#MDGL
#nashsemodough
#tern
#resmetirom
#mdgl
#vktx
|
18 days ago @semodough
$LPTX - sentiment changing last few weeks - get in early or wait & see data - $LPTX https://t.co/udGUHgUJP3
|
#LPTX
#lptx
#sentiment
#changing
#wait
#weeks
|
18 days ago @semodough
$ICPT #NASH Advisory Committee on Intercept’s $ICPT obeticholic acid in NASH on Friday, May 19.
|
#ICPT
#icpt
#nash
#obeticholic
#acid
#intercept
|
18 days ago @CatalystWatcher
$GRCL 100k block. Fund continues to load here.
|
#GRCL
#catalystwatcher
#load
#grcl
#block
#fund
|
18 days ago @FlashAlert_me
$OMER [15s. delayed] filed SEC form 4: Director Perkinson Diana T.:
Transacted Derivative Securities on 2023-05-12… https://t.co/WPPO5W6vxt
|
#OMER
#transacted
#perkinson
#omer
#diana
#director
|
18 days ago @FlashAlert_me
$OMER [15s. delayed] filed SEC form 3: Director Perkinson Diana T.:
https://t.co/gpBZp4Kojz
|
#OMER
#perkinson
#omer
#diana
#director
#delayed
|
18 days ago @gurgavin
@pitdesi $CYTO SEEMS TO BE THE SMALLEST ONE ON NASDAQ
MARKET CAP OF JUST $1.1 M
https://t.co/CSJ9KdgQ3y
|
#CYTO
#cyto
#smallest
#seems
#nasdaq
#co
|
18 days ago @semodough
$MREO strong conviction by SUVRETTA CAPTIAL disclosed May 15 continues to hold huge position.
$MREO 10.87% Owner… https://t.co/xDsix7kYZw
|
#MREO
#mreo
#suvretta
#captial
#owner
#disclosed
|
18 days ago @ACInvestorBlog
$TNXP another recent RS name like $CYCN
|
#CYCN
#cycnacinvestorblog
#tnxp
#name
#recent
#another
|
18 days ago @semodough
$LPTX BAKERS Samsara cormorant all know $LPTX has active drug - catalysts picking up here https://t.co/1ROJoDXWAg
|
#LPTX
#lptx
#samsara
#cormorant
#bakers
#catalysts
|
18 days ago @semodough
RT @BertrandBio: $AMGN $HZNP $PFE $SGEN
|
#PFE
#sgensemodough
#bertrandbio
#amgn
#hznp
#PFE
|
18 days ago @semodough
BMO $GILD upgrading Gilead to Outperform and increasing our target to $100 from $90 based on: 1) What we believe to… https://t.co/X78vhEqETn
|
#GILD
#upgrading
#gild
#gilead
#outperform
#increasing
|
18 days ago @biostocks
$MDGL PT raised to $350 at Oppenheimer.
|
#MDGL
#oppenheimer
#biostocks
#raised
#MDGL
|
18 days ago @FlashAlert_me
$VSTM [15s. delayed]: Issued Press Release on May 16, 08:00:00: Verastem Oncology Appoints Karin Tollefson, PhD, to… https://t.co/Z7eOn4QHb6
|
#VSTM
#vstm
#verastem
#tollefson
#karin
#appoints
|
19 days ago @biostocks
$GILD and $RCUS Expand Partnership to Include Research Programs in Inflammation.
Gilead to Have Early Option to Exc… https://t.co/A9eRLaoIPg
|
#GILD
#inflammation
#partnership
#programs
#expand
#include
|
19 days ago @biostocks
$TERN topline data from Phase 2a DUET trial of TERN-501 in NASH expected in third quarter of 2023.
Cash, cash equiv… https://t.co/O5Ph0qHGzZ
|
#TERN
#tern
#cash
#nash
#topline
#duet
|
19 days ago @semodough
JPM $PTGX caught up with PTGX’s CEO and CDA to discuss IP23 data. Overall, the data was additive to our understandi… https://t.co/ggr9VEpdUb
|
#PTGX
#ptgx
#understandi
#caught
#additive
#discuss
|
19 days ago @semodough
JPM $DAWN plenty of catalysts over next few months see shares as having potential to come out of aforementioned eve… https://t.co/4xzRqB4fjZ
|
#DAWN
#dawn
#plenty
#aforementioned
#catalysts
#come
|
19 days ago @semodough
RT @CAMM29160: $NVCT now will have 2 targeted oncology drugs in the clinic. Reminder: '900 has been shown in two separate papers (written b…
|
#NVCT
#oncology
#nvct
#written
#drugs
#clinic
|
19 days ago @semodough
RT @JD4for4: $NVCT announces FDA IND for NXP900, a highly selective/potent SRC/YES1 kinase inhibitor, which has shown robust single agent a…
|
#NVCT
#selective
#agent
#nvct
#potent
#src
|
19 days ago @semodough
$MREO very good news Rubrics capital disclosed May 12 1st qtr 13F holdings: No changes & continued to hold huge p… https://t.co/M5BDnD4Zo0
|
#MREO
#rubrics
#mreo
#disclosed
#holdings
#huge
|
19 days ago @semodough
$MREO - rubric their work and good overview that I keep reading https://t.co/2nanUi7u5U https://t.co/SorTdVAaBu
|
#MREO
#sortdvaabusemodough
#rubric
#mreo
#overview
#reading
|
19 days ago @CatalystWatcher
$GRCL daily looking good. KOL event next Monday followed by ASCO data drop May 25th. I get the vibe they are really… https://t.co/9i9tgJWy7S
|
#GRCL
#vibe
#asco
#grcl
#followed
#event
|
19 days ago @CatalystWatcher
Some big $GRCL buys by Orbimed and Sphera in Q1. https://t.co/tJVKaz9ThD
|
#GRCL
#sphera
#buys
#grcl
#co
#GRCL
|
19 days ago @semodough
$LPTX Leap Therapeutics Reports First Quarter 2023 Financial Results | Leap Therapeutics, Inc. https://t.co/xEuP30G3Po
|
#LPTX
#leap
#therapeutics
#lptx
#results
#quarter
|
21 days ago @semodough
$IFRX Q2 2023 – Monotherapy data from the Phase 2 study with vilobelimab in cSCC
Q3 2023 – Potential first commerci… https://t.co/QxhqBWQz9d
|
#IFRX
#vilobelimab
#cscc
#ifrx
#monotherapy
#study
|
21 days ago @semodough
$VSTM data update from the interim analysis from RAMP 201 study of avutometinib (avuto’; VS-6766) in combination wi… https://t.co/xNRejGe08y
|
#VSTM
#vstm
#avutometinib
#avuto
#interim
#ramp
|
21 days ago @semodough
$TARS H2 2023 – Topline Phase IIa Carpo PoC data with TP-05 for Lyme disease prevention H2 2023 – Initiate Phase II… https://t.co/O4jy2eK6S3
|
#TARS
#phase
#tars
#topline
#initiate
#disease
|
22 days ago @semodough
All 3 green today $AXSM $BTAI $ITCI https://t.co/0XTB21Uyx8
|
#AXSM
#btai
#axsm
#green
#today
#AXSM
|
22 days ago @TradeWithAlerts
Nice print for $PFE Size: 283809 Price: 37.71 Amount: $10,702,437.39 Time: 930
See more: https://t.co/9Zy8l0wcC6
Jo… https://t.co/N5z7xDPehf
|
#PFE
#jo
#print
#size
#nice
#amount
|
22 days ago @semodough
RT @ej23ny: $MREO
1st 2023 QTR 13F
Citi Group
Added 1.129M shares building big position
JP Morgan
Added 281K shares
Tejara Capita…
|
#MREO
#added
#tejara
#mreo
#citi
#semodough
|
22 days ago @OpenOutcrier
+Initiations 5/12: $BMEA $GPRE $LNZA $PANW $SGRY $SOFI $TNET
.
-Initiations 5/12: $GMAB
|
#BMEA
#initiations
#tnet
#sgry
#lnza
#gpre
|
22 days ago @CatalystWatcher
Bought more $GRCL. Up to 50k shares. ER Monday and ASCO data May 25th. Company is now moving into Lupus (not disclo… https://t.co/0zFcb9X4oO
|
#GRCL
#lupus
#disclo
#asco
#grcl
#monday
|
22 days ago @BreakoutStocks
$NERV is up 350% since breaking out recently https://t.co/DatdEssV7K
|
#NERV
#nerv
#breaking
#recently
#since
#NERV
|
22 days ago @semodough
Mizuho First AD Agitation Drug Approved; A Positive for Patients, and $AXSM, $BTAI, $ITCI https://t.co/OCIm6rbQU3
|
#AXSM
#itci
#axsm
#agitation
#mizuho
#patients
|
22 days ago @biostocks
$BMEA initiated with an Overweight at Barclays. PT $50
|
#BMEA
#initiated
#overweight
#barclays
#BMEA
|
22 days ago @semodough
LIFESCI $OLMA (OUTPERFORM,$21.00 PT): ESMO Breast Combo Data with OP-1250 + Palbociclib Look Competitive Across the… https://t.co/il0GuoNdXY
|
#OLMA
#combo
#breast
#outperform
#competitive
#across
|
23 days ago @semodough
With growing interest in the antibody-drug conjugate (ADC) space $VINC has been perking up lately https://t.co/qaMjopwUg2
|
#VINC
#vinc
#conjugate
#antibody
#lately
#drug
|
23 days ago @stocks
What's going on with medical/lab equipment companies?
|
#BMY
#firms
#healthcare
#benefit
#industry
#still
|
23 days ago @FlashAlert_me
$VERU [15s. delayed] filed SEC form 4: Director Hyun Grace:
Transacted Derivative Securities on 2023-05-09. https://t.co/F7Q7myqkDS
|
#VERU
#transacted
#hyun
#derivative
#veru
#director
|
23 days ago @semodough
$PTGX https://t.co/pWj0TwtxNu
|
#PTGX
#ptgx
#PTGX
|
23 days ago @semodough
$VINC IND filing for VIP943, a next-generation antibody-drug conjugate #ADC for treatment of CD123+ hematologic mal… https://t.co/RcfaTl5PSJ
|
#VINC
#vinc
#adc
#conjugate
#antibody
#generation
|
23 days ago @CatalystWatcher
$GRCL some interesting accumulation going on ahead of ER Monday.
|
#GRCL
#accumulation
#catalystwatcher
#grcl
#interesting
#monday
|
23 days ago @CatalystWatcher
RT @WebChronicleTo1: $GRCL Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in RRMM and B-NHL…
|
#GRCL
#rrmm
#gracell
#fastcar
#biotechnologies
#dual
|
23 days ago @CatalystWatcher
$GRCL 100% ORR in relapsed/refractory B-cell acute lymphoblastic leukemia
|
#GRCL
#leukemiacatalystwatcher
#relapsed
#lymphoblastic
#refractory
#acute
|
23 days ago @biostocks
$MIRM Announces Enrollment Completion in Phase 2b EMBARK Biliary Atresia Study.
Topline Data 2H'23
|
#MIRM
#topline
#mirm
#embark
#biliary
#atresia
|
23 days ago @semodough
Stifel $KURA weakness following phase 1 ziftomenib R/R AML data at ASH22 is attributable to market’s lower competit… https://t.co/LQ46A1YrtU
|
#KURA
#ziftomenib
#kura
#competit
#stifel
#attributable
|
23 days ago @semodough
BAML $APLS encouraged by the initial strength of the Syfovre launch supporting the large commercial opportunity in… https://t.co/BzUoB6sEk3
|
#APLS
#syfovre
#apls
#baml
#supporting
#encouraged
|
23 days ago @CatalystWatcher
RT @JacobPlieth: $GRCL just started a trial of GC012F (CD19/BCMA Car-T) in lupus https://t.co/yE21g9E4Ev
|
#GRCL
#lupus
#jacobplieth
#bcma
#grcl
#trial
|
23 days ago @semodough
$RARE $MREO #OI - KOL definitely expert on #OI - hopefully will be replay or transcript lots to digest - went over… https://t.co/uICJByVN6p
|
#MREO
#mreo
#expert
#digest
#replay
#lots
|
23 days ago @InvestorsLive
$PLX if you couldn't figure it out yesterday ? https://t.co/f4UFN7E9ZC
|
#PLX
#couldn
#figure
#yesterday
#PLX
|
23 days ago @semodough
$AXSM bofa starting now AXSOME THERAPEUTICS INC https://t.co/eTayOTJl5E
|
#AXSM
#axsome
#bofa
#axsm
#therapeutics
#starting
|
23 days ago @semodough
Lundbeck Reulti approved https://t.co/bbwHvrl1Ao $AXSM $BTAI https://t.co/38mZ7TD6hu
|
#AXSM
#reulti
#lundbeck
#btai
#axsm
#approved
|
23 days ago @semodough
CEO $AXSM - very confident plenty of growth drivers in near term https://t.co/Ol3YmLVqAD
|
#AXSM
#axsm
#plenty
#drivers
#near
#confident
|
23 days ago @semodough
$JAZZ steady growth trajectory, with revenues up +10% to $892.8mn/Cons. $897mn and up +9% (EPS $3.95/Cons $4.24, +6… https://t.co/fVY0YzG64q
|
#JAZZ
#cons
#trajectory
#steady
#revenues
#growth
|
23 days ago @semodough
$RARE $MREO Very important milestone achieved initiated phase 3 pediatric trial
phase 3 pediatric study Setrusumab… https://t.co/UU5GYlw2uG
|
#MREO
#pediatric
#phase
#setrusumab
#mreo
#milestone
|
23 days ago @semodough
Mizuho $AXSM, Buy, $95.00 PT): 1Q Wrap: Raising Our Near-term Auvelity Outlook, and Moving Our PT Higher to $95
|
#AXSM
#axsm
#auvelity
#wrap
#mizuho
#raising
|
23 days ago @biostocks
$FENC Q1 PEDMARK net sales $1.67M
|
#FENC
#pedmark
#fenc
#sales
#FENC
|
24 days ago @JonahLupton
@michaelfrazis Stock is so cheap but it’s still being hurt by the potential patent challenge from $TEVA —
I think I have that right.
|
#TEVA
#teva
#jonahlupton
#patent
#hurt
#challenge
|
24 days ago @FlashAlert_me
$BLTE [15s. delayed, acc.~90%, always check] Earnings Release May 10, 19:58:00: Q1: GAAP EPS of -$0.33 https://t.co/kGMZ0RvytY
|
#BLTE
#blte
#check
#gaap
#delayed
#always
|
24 days ago @FlashAlert_me
$BLTE [15s. delayed]: Issued Press Release on May 10, 19:58:00: Belite Bio Reports First-Quarter 2023 Operational H… https://t.co/DCqxghb18Y
|
#BLTE
#belite
#blte
#operational
#issued
#delayed
|
24 days ago @semodough
$DAWN confidence seems to be growing going into ORAL #ASCO2023 webcasts growing - also JPM nice comments along with… https://t.co/Nm1b0nCZLl
|
#DAWN
#growing
#webcasts
#oral
#dawn
#along
|
24 days ago @semodough
$RARE good week - look forward to the #Setrusumab call tomorrow Guggenheim is doing $RARE $MREO https://t.co/hbhKs5dtLA
|
#MREO
#rare
#setrusumab
#guggenheim
#forward
#tomorrow
|
24 days ago @semodough
@OMillionaires $AXSM - catalysts
Coming - shorts still piling in multiple Price target raises after good quarter th… https://t.co/LBYqfdlVVw
|
#AXSM
#piling
#lbyqfdlvvwsemodough
#raises
#omillionaires
#axsm
|
24 days ago @semodough
@ScottDu27795048 Agree and analyst here did raise PT on $AXSM slightly this week even though his model still way of… https://t.co/0yLy7WHheT
|
#AXSM
#axsm
#agree
#analyst
#model
#raise
|
24 days ago @semodough
$ICVX IVX-A12 (RSV+hMPV) Phase 1 topline interim data expected in 2Q 2023 -
Initiation of IVX-A12 Phase 2 trial exp… https://t.co/xHfxTEVgQV
|
#ICVX
#phase
#xhfxtevgqvsemodough
#topline
#initiation
#hmpv
|
24 days ago @semodough
$ICVX catalysts https://t.co/tbTU6ElkhW https://t.co/4xOmHz1jvn
|
#ICVX
#icvx
#catalysts
#ICVX
|
24 days ago @OpenOutcrier
$TEVA (-7.0% pre) Teva Pharmaceutical reports mixed Q1 earnings; reaffirms FY23 outlook - SA
https://t.co/Ur6qix3ZE2
|
#TEVA
#teva
#reaffirms
#pharmaceutical
#mixed
#outlook
|
24 days ago @TradeWithAlerts
Nice print for $PFE Size: 297297 Price: 38.63 Amount: $11,484,583.11 Time: 930
See more: https://t.co/9Zy8l0wcC6
Jo… https://t.co/EKTvAIHw11
|
#PFE
#print
#size
#nice
#amount
#time
|
24 days ago @biostocks
$SYRS initial data from the randomized portion of SELECT-AML-1 trial expected in Q4.
On track to complete enrollmen… https://t.co/pimbFYuchs
|
#SYRS
#syrs
#randomized
#enrollmen
#select
#trial
|
24 days ago @semodough
RT @BiopharmIQ: @Pharmdca Lots of upcoming catalysts for $VKTX $TERN & $MDGL!? https://t.co/4Aqeegij1o
|
#MDGL
#tern
#vktx
#mdgl
#catalysts
#lots
|
24 days ago @semodough
@OMillionaires Not sure it’s wrong. Just plenty of risk looking at $MDGL data and knowing what’s known on $VKTX ear… https://t.co/RECbuM6tLM
|
#MDGL
#omillionaires
#vktx
#mdgl
#knowing
#plenty
|
24 days ago @semodough
RT @TomSilver39: Oppenheimer:" $AUPH 1Q23 Review: Auspicious Start to 2023....M&A..." https://t.co/3syE7xVPkL
|
#AUPH
#oppenheimer
#auph
#review
#start
#co
|
24 days ago @biostocks
$PHAT on track to resubmit erosive esophagitis (Erosive GERD) NDA this Q
|
#PHAT
#erosive
#resubmit
#qbiostocks
#gerd
#esophagitis
|
24 days ago @ACInvestorBlog
$PALI patent news
|
#PALI
#pali
#patent
#PALI
|
24 days ago @semodough
When you look at $RETA story & FDA approving. Imho bodes very well for other companies moving forward in rare unme… https://t.co/ifCMhBOMsC
|
#RETA
#unme
#imho
#ifcmhbomscsemodough
#reta
#approving
|
24 days ago @biostocks
$NERV FDA confirms acceptance of the filing of the NDA for roluperidone
The application has been granted a standard review.
PDUFA 02/26/24
|
#NERV
#roluperidone
#nerv
#granted
#confirms
#acceptance
|
24 days ago @unusual_whales
Largest dark pools today (15 min delayed):
$CTIC - Prem: $22,701,737. Size: 2,550,757
Link (+ live flow):… https://t.co/UN1tR1A7V1
|
#CTIC
#prem
#dark
#ctic
#link
#largest
|
24 days ago @biostocks
$PLX and Chiesi Announce FDA Approval of ELFABRIO for the Treatment of Fabry Disease
https://t.co/AhGJkRLp5i
|
#PLX
#fabry
#elfabrio
#chiesi
#disease
#approval
|
24 days ago @semodough
RT @BiotechElmo: $CTIC ?
Sobi to Acquire CTI Bioparma
Transaction Price of $9.10 Per Share Represents Compelling 89% Premium
https://t.…
|
#CTIC
#biotechelmo
#bioparma
#sobi
#represents
#ctic
|
24 days ago @biostocks
Sobi to acquire $CTIC for $9.10 per share in cash.… https://t.co/lgA3i6M5rs
|
#CTIC
#sobi
#ctic
#acquire
#cash
#share
|
25 days ago @ACInvestorBlog
$PALI woke up !!
|
#PALI
#woke
#pali
#acinvestorblog
#PALI
|
25 days ago @semodough
RT @eomes_biotech: $VKTX confident imminent NASH readout will be positive. Just did a quick comp re efficacy with $MDGL Resme trial - I kno…
|
#MDGL
#vktx
#resme
#readout
#nash
#eomes_biotech
|
25 days ago @semodough
RT @Steven38199694: $MREO I had a Zoom call with #Mereo's CEO today. Impressive biotech company advancing 3 main programs:1. Setrusumab in…
|
#MREO
#setrusumab
#mreo
#mereo
#zoom
#advancing
|
25 days ago @FlashAlert_me
$MORF [15s. delayed] filed SEC form 4: President Rogers Bruce:
Converted securities 16,000 of Common Stock at pric… https://t.co/A83miqj53O
|
#MORF
#rogers
#morf
#bruce
#pric
#converted
|
25 days ago @TradeWithAlerts
Nice print for $PFE Size: 255954 Price: 38.44 Amount: $9,838,871.76 Time: 930
See more: https://t.co/9Zy8l0wcC6
Joi… https://t.co/hQ74yZ2EI4
|
#PFE
#print
#size
#amount
#nice
#time
|
25 days ago @biostocks
$GILD Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
https://t.co/dKMvbXS5El
|
#GILD
#xinthera
#oncology
#inflammation
#gild
#strengthens
|
25 days ago @semodough
RT @BioStocks: $GILD Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
https://t.co/dKMvbXS5El
|
#GILD
#xinthera
#oncology
#inflammation
#gild
#strengthens
|
25 days ago @semodough
$MDGL Resmetirom new drug application (NDA) filing on track for Q2 2023
Resmetirom has received Breakthrough Therap… https://t.co/Pz1k54Sg0B
|
#MDGL
#resmetirom
#therap
#breakthrough
#mdgl
#application
|
25 days ago @biostocks
RT @semodough: $MDGL Resmetirom new drug application (NDA) filing on track for Q2 2023
Resmetirom has received Breakthrough Therapy designa…
|
#MDGL
#resmetirom
#designa
#breakthrough
#semodough
#mdgl
|
25 days ago @biostocks
$AUPH Announces Kidney Biopsies Sub-study Data from the LUPKYNIS AURORA 2 Clinical Trial Presented at Congress of C… https://t.co/z0XQlOWURm
|
#AUPH
#lupkynis
#kidney
#biopsies
#auph
#presented
|
25 days ago @biostocks
$HOOK First Person Dosed in Phase 1a/b Clinical Trial of HB-400, in Collaboration with Gilead, for Treatment of Hepatitis B. $GILD
|
#GILD
#gildbiostocks
#hepatitis
#gilead
#dosed
#person
|
25 days ago @semodough
Nope Baml on $AXSM Based on 1Q + 2Q weekly TRx trends bump FY23 Auvelity sales to $93m (prior $80m) and out-year Au… https://t.co/cznkQlE1FF
|
#AXSM
#bump
#nope
#baml
#auvelity
#trends
|
25 days ago @FlashAlert_me
$TRVN [15s. delayed] filed form 424B5 on May 09, 07:09:25 https://t.co/QWxfUMnfWz
|
#TRVN
#qwxfumnfwzflashalert_me
#trvn
#delayed
#filed
#form
|
25 days ago @FlashAlert_me
$TRVN [15s. delayed] filed form 8-K on May 09, 07:10:23 https://t.co/20pSPz69Bv
|
#TRVN
#trvn
#delayed
#filed
#form
#co
|
26 days ago @semodough
Very unusual nothing I seen from BAML on $AXSM today -usually very quick - could be they finally changed course https://t.co/6oMJCLNUWO
|
#AXSM
#baml
#unusual
#axsm
#nothing
#changed
|
26 days ago @semodough
$AXSM catalysts AXS-12 Ph3 topline in narcolepsy on track for 2Q23,
Ph3 ADA topline of AXS-05, ADVANCE-2, on track… https://t.co/8YDoYQwEiW
|
#AXSM
#topline
#track
#narcolepsy
#catalysts
#axsm
|
26 days ago @DilutionTracker
Daily Dilution Update 05/08
Offering
$LEXX $2m @ $0.95 w/ 100% wrt cov
$PBLA S-1 filed
ATM
$APM $1.5m
Shelf
$FGH… https://t.co/LtMOqGtQuR
|
#APM
#pbla
#lexx
#shelf
#wrt
#dilution
|
26 days ago @Mini_Tradez
Here is why my day was a bit choppy ⬇️
All of the focus and volume was on $TRVN while I was trying to play other p… https://t.co/xMc5kZBt1F
|
#TRVN
#choppy
#trvn
#trying
#play
#focus
|
26 days ago @Mini_Tradez
$TRVN- $1.60 idea to $3.70 for an INSANE run ?
Click the link to join the discord. We kill it again tomorrow!
https://t.co/5pxz6YsLZz
|
#TRVN
#insane
#kill
#discord
#trvn
#click
|
26 days ago @FlashAlert_me
$XNCR [15s. delayed] filed form 10-Q on May 08, 17:15:39 https://t.co/7mrYGWtI3q
|
#XNCR
#xncr
#delayed
#filed
#form
#co
|
26 days ago @OpenOutcrier
$ACRS (-2.6% pre) Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update… https://t.co/EVreKZ7D2r
|
#ACRS
#acrs
#aclaris
#therapeutics
#provides
#update
|
26 days ago @TradeWithAlerts
Nice print for $PFE Size: 369227 Price: 38.58 Amount: $14,244,777.66 Time: 930
See more: https://t.co/9Zy8l0wcC6
Jo… https://t.co/RCBKAdtNgf
|
#PFE
#rcbkadtngftradewithalerts
#jo
#print
#size
#amount
|
26 days ago @semodough
$TARS H2 2023 Topline Phase IIa Carpo PoC data with TP-05 for Lyme disease prevention
H2 2023 – Initiate Phase IIb… https://t.co/XInaJIYLKr
|
#TARS
#phase
#xinajiylkrsemodough
#tars
#lyme
#carpo
|
26 days ago @biostocks
RT @semodough: $AXSM Auvelity® 1Q 2023 net product sales of $15.7 million
Total 1Q 2023 net product sales of $28.6 million
Total 1Q 2023…
|
#AXSM
#product
#sales
#total
#million
#biostocks
|
26 days ago @semodough
Interesting to see what Baml has to say n $AXSM today ? ?? https://t.co/akDR5vLvbz
|
#AXSM
#baml
#axsm
#interesting
#see
#today
|
26 days ago @semodough
TRUIST $AXSM PT 150 Quick Thoughts: Huge Topline Beat On Auvelity At $15.7M vs Our $8M and Street's $10M. https://t.co/MxdCPeJxX2
|
#AXSM
#truist
#topline
#auvelity
#axsm
#huge
|
26 days ago @semodough
COWEN $AXSM PT125 product continues to look strong, with over 21k treated patients endof Q1. MGT continues to expec… https://t.co/b7kgDitcwB
|
#AXSM
#continues
#expec
#endof
#cowen
#treated
|
26 days ago @ACInvestorBlog
$TRVN +200% this morning. Pivot points on the chart. No pos. https://t.co/DoOv2C64op
|
#TRVN
#trvn
#pivot
#points
#chart
#morning
|
26 days ago @Bullish_Trades
$TRVN .60’s to $2.67 now and halted.
Tons of low floats under $1 to keep an eye on
|
#TRVN
#onbullish_trades
#tons
#halted
#floats
#trvn
|
26 days ago @Mini_Tradez
$TRVN NOW HITTING 330% MOVE
This is insane and caught it with the Team
1.60--->2.79 now
Best Team in the world,… https://t.co/dTrOAvd2tY
|
#TRVN
#team
#insane
#hitting
#trvn
#caught
|
26 days ago @biostocks
$TERN initiated with an Outperform at BMO. PT $18
|
#TERN
#tern
#initiated
#outperform
#TERN
|
26 days ago @semodough
RT @PersimmonTI: $MREO - State of Play
At present, I view $MREO “lead” candidate with respect to potential for alpha generation as Alvele…
|
#MREO
#mreo
#persimmonti
#alvele
#respect
#generation
|
26 days ago @FlashAlert_me
$OLMA [15s. delayed]: Issued Press Release on May 08, 07:06:00: Olema Oncology Announces Upcoming Poster Presentati… https://t.co/mDDXub1c96
|
#OLMA
#presentati
#poster
#olema
#olma
#oncology
|
26 days ago @semodough
$AXSM 15.7 Auvelity sales
|
#AXSM
#salessemodough
#auvelity
#axsm
#AXSM
|
26 days ago @semodough
$AXSM Auvelity® 1Q 2023 net product sales of $15.7 million
Total 1Q 2023 net product sales of $28.6 million
Total… https://t.co/kZku6BC9F8
|
#AXSM
#product
#sales
#total
#million
#auvelity
|
26 days ago @biostocks
$AXSM Anticipated Milestones
Regulatory and Commercial:
AXS-07 for migraine, NDA resubmission 2H'23
AXS-14 for fibr… https://t.co/2V4h7elgnM
|
#AXSM
#resubmission
#milestones
#fibr
#migraine
#anticipated
|
27 days ago @semodough
$CLDX Also at EAACI, a First Look at Cholinergic Urticaria Cohort; physicians that this could represent one of the… https://t.co/OgD1XEzLq2
|
#CLDX
#urticaria
#eaaci
#cohort
#cldx
#cholinergic
|
27 days ago @semodough
$CLDX catalyst Phase 1b Data of Barzo in CSU at EAACI, June 9-11. Recall that CLDX announced updated Phase 1b data… https://t.co/2vrzei5T5G
|
#CLDX
#cldx
#phase
#eaaci
#catalyst
#recall
|
27 days ago @RichardMoglen
RT @RaiTrades: Recent Highest Volume Ever (HVE's)
$BMEA
$OSCR
$IMGN
$IOT
$MAXN
$NNOX
$ONON
|
#BMEA
|
28 days ago @semodough
$ITCI pipeline/catalyst https://t.co/LSsccy8U01 https://t.co/Nrfk228E1v
|
#ITCI
#catalyst
#pipeline
#ITCI
|
29 days ago @stocks
LQDA Prediction
|
#LQDA
#lqda
#united
#share
#share_button
#exploring_lqda
|
29 days ago @semodough
$ITCI Caplyta strong quarter, with sales of $94.7M consensus $91M/$92M est., driven by high patient demand. Opex wa… https://t.co/O0bVv93urg
|
#ITCI
#caplyta
#opex
#patient
#driven
#consensus
|
29 days ago @stocks
$SGEN spread at 15% now looking like steal of a Merger play
|
#PFE
#sgen
#would
#solid
#merger
#regulation
|
29 days ago @FlashAlert_me
$MORF [15s. delayed] filed SEC form 4: President and CEO Tipirneni Praveen P.:
Disposed 3,597 of Common Stock at p… https://t.co/5rtRGYggtd
|
#MORF
#tipirneni
#morf
#disposed
#president
#delayed
|
29 days ago @semodough
$MREO - Mereo BioPharma transfers ADS listing from Nasdaq Global Market to Nasdaq Capital Market
|
#MREO
#nasdaq
#transfers
#mreo
#mereo
#biopharma
|
29 days ago @semodough
RT @BuyLowRetire: $AXSM I see Auvelity becoming Tier 2 in several formularies as of May 1st. https://t.co/axDKabGFoC
|
#AXSM
#buylowretire
#axsm
#axdkabgfocsemodough
#auvelity
#tier
|
29 days ago @semodough
RT @sentivcapital: $APLS Wanted to save this until earnings were out. GA is one market whose size has been severely underestimated, even by…
|
#APLS
#underestimated
#sentivcapital
#save
#severely
#semodough
|
29 days ago @semodough
@sentivcapital $APLS 12 million short are they nuts https://t.co/LgDb87Tawo
|
#APLS
#sentivcapital
#apls
#million
#short
#APLS
|
29 days ago @biostocks
$FGEN the proportion of patients who achieved red blood cell transfusion independence in the first 28 weeks was 47.… https://t.co/iXhE0NpG7v
|
#FGEN
#transfusion
#fgen
#cell
#blood
#patients
|
29 days ago @TradeWithAlerts
Nice print for $PFE Size: 304817 Price: 38.5 Amount: $11,735,454.50 Time: 930
See more: https://t.co/9Zy8l0wcC6
Joi… https://t.co/21DfkySxdX
|
#PFE
#print
#size
#amount
#nice
#price
|
29 days ago @semodough
LIFESCI $CLDX (OUTPERFORM,$65.00 PT): Q1 2023 Earnings: Phase 2 CSU Data with Barzolvolimab Expected in Late 2023/Q… https://t.co/skZuS5nVaC
|
#CLDX
#cldx
#barzolvolimab
#outperform
#phase
#late
|
29 days ago @CatalystWatcher
$CYCN One final week ahead before shareholder meeting May 15th (where they lose 4 of the BOD reviewing Hecht's offe… https://t.co/pkEIDExJyA
|
#CYCN
#reviewing
#cycn
#lose
#shareholder
#meeting
|
29 days ago @OpenOutcrier
$SNGX (-34.6% pre) Soligenix, Inc. (SNGX) Announces $12M Share and Warrant Offering - SI
https://t.co/TYhKKCOTeY
|
#SNGX
#sngx
#warrant
#tyhkkcoteyopenoutcrier
#soligenix
#announces
|
29 days ago @johnscharts
$APLS All Time Highs moving on earnings
Sales 212%
#22 Industry
Chart courtesy of @MarketSmith https://t.co/mKwalJ18Cj
|
#APLS
#marketsmith
#apls
#courtesy
#highs
#moving
|
29 days ago @semodough
$APLS buyers early Monday rewarded today https://t.co/KqWckGmckl
|
#APLS
#rewarded
#apls
#monday
#buyers
#early
|
29 days ago @semodough
PIPER $PTGX Overweight PT 35 Reports 1Q23: FRONTIER-1 Data Most Likely At WCD; PV VERIFY Is Progressing Well- inter… https://t.co/UARhGsdbY3
|
#PTGX
#pv
#frontier
#verify
#piper
#ptgx
|
29 days ago @semodough
Laden $LQDA: Yutrepia Legal Path Clear; Launch Expected by Mid-2024; Reiterate Buy, $15
|
#LQDA
#yutrepia
#reiterate
#laden
#lqda
#legal
|
29 days ago @semodough
Baird $APLS early uptake points to high interest in Syfovre and helps validate GA as a major market opportunity, ei… https://t.co/fySEhDlHg9
|
#APLS
#validate
#uptake
#syfovre
#ei
#baird
|
1 month ago @FlashAlert_me
$CTIC [15s. delayed]: Issued Press Release on May 04, 19:55:00: CTI BioPharma Announces Inducement Grants Under Nas… https://t.co/C6SQ6c48Pr
|
#CTIC
#ctic
#biopharma
#inducement
#grants
#issued
|
1 month ago @biostocks
$MORF director Timothy Springer buys 1.05M shares for $47.25M
|
#MORF
#timothy
#springer
#morf
#buys
#director
|
1 month ago @FlashAlert_me
$NRIX [15s. delayed] filed SEC form 4: Director GREGORY JULIA P:
Transacted Derivative Securities on 2023-05-04. https://t.co/60TDB5ZbEB
|
#NRIX
#nrix
#transacted
#derivative
#delayed
#director
|
1 month ago @FlashAlert_me
$NRIX [15s. delayed] filed SEC form 4: Director Lacey David L.:
Transacted Derivative Securities on 2023-05-04. https://t.co/BV29f2YlqJ
|
#NRIX
#nrix
#david
#transacted
#derivative
#delayed
|
1 month ago @FlashAlert_me
$NRIX [15s. delayed] filed SEC form 4: Director Kunkel Lori Anne:
Transacted Derivative Securities on 2023-05-04. https://t.co/CdlQ6RdPFJ
|
#NRIX
#anne
#nrix
#transacted
#derivative
#delayed
|
1 month ago @FlashAlert_me
$NRIX [15s. delayed] filed SEC form 4: Director Saltzman Edward C:
Transacted Derivative Securities on 2023-05-04. https://t.co/HJ6JVpvJDO
|
#NRIX
#saltzman
#edward
#nrix
#transacted
#derivative
|
1 month ago @FlashAlert_me
$NRIX [15s. delayed] filed SEC form 4: Director Reinsdorf Judith A:
Transacted Derivative Securities on 2023-05-04… https://t.co/YJZkrLbyVG
|
#NRIX
#yjzkrlbyvgflashalert_me
#reinsdorf
#nrix
#transacted
#derivative
|
1 month ago @FlashAlert_me
$NRIX [15s. delayed] filed SEC form 4: Director Silva Paul M:
Transacted Derivative Securities on 2023-05-04. https://t.co/Xrt3MVBBrO
|
#NRIX
#silva
#paul
#nrix
#transacted
#derivative
|
1 month ago @InvestorsLive
Done with $SNGX running out of time for round trip - nice fade from pre market entry. https://t.co/VluBPxkFtr
|
#SNGX
#vlubpxkftrinvestorslive
#fade
#sngx
#trip
#round
|
1 month ago @InvestorsLive
$SNGX LODs
|
#SNGX
#sngx
#SNGX
|
1 month ago @FlashAlert_me
$GILD [15s. delayed] filed SEC form 4: Insider BARTON JACQUELINE K:
Granted 1,887 of Common Stock at price $0 on 2… https://t.co/p2eepUXUS8
|
#GILD
#barton
#gild
#granted
#delayed
#filed
|
1 month ago @FlashAlert_me
$GILD [15s. delayed] filed SEC form 4: Insider Kramer Kelly A.:
Transacted Derivative Securities between 2023-05-0… https://t.co/0RFyyQIf20
|
#GILD
#transacted
#gild
#derivative
#delayed
#filed
|
1 month ago @FlashAlert_me
$MORF [15s. delayed] filed SEC form 4: Director SPRINGER TIMOTHY A:
Acquired 1,050,000 of Common Stock at price $4… https://t.co/j1P8m8b5G4
|
#MORF
#springer
#morf
#timothy
#acquired
#delayed
|
1 month ago @cfromhertz
$APLS #APLS earnings (Bloomberg) https://t.co/8Ev6J6HKjZ
|
#APLS
#apls
#bloomberg
#earnings
#APLS
|
1 month ago @semodough
$APLS BOOM Generated U.S. net product revenues of $18.4 million for SYFOVRE™ (pegcetacoplan injection) and $20.4 mi… https://t.co/8PllfVHakZ
|
#APLS
#syfovre
#pegcetacoplan
#apls
#boom
#generated
|
1 month ago @semodough
$APLS 6,000 commercial vials shipped to physicians in March alone, the trajectory looks very promising.” https://t.co/A8JBYPDdxs
|
#APLS
#vials
#shipped
#physicians
#trajectory
#promising
|
1 month ago @semodough
$RARE $MREO Hearing Guggenheim doing KOL call with DR VERNON SUTTON on MAY 11 https://t.co/BGnVxKoPm2
|
#MREO
#vernon
#sutton
#mreo
#rare
#guggenheim
|
1 month ago @semodough
$TGTX - profitability going forward - $AUPH Total cost of sales and operating expenses for the three months were $6… https://t.co/ey92GkQYF5
|
#AUPH
#tgtx
#auph
#profitability
#expenses
#forward
|
1 month ago @TradeWithAlerts
Nice print for $PFE Size: 379717 Price: 38.2 Amount: $14,505,189.40 Time: 930
See more: https://t.co/9Zy8l0wcC6
Joi… https://t.co/9O7a0KgkHU
|
#PFE
#joi
#print
#size
#amount
#nice
|
1 month ago @ACInvestorBlog
$CYTO long-term chart. The declining EMA100 has been the major res for the stock everytime it spikes higher. Defini… https://t.co/QRgKBiPz6i
|
#CYTO
#everytime
#spikes
#declining
#cyto
#chart
|
1 month ago @ACInvestorBlog
$CYTO took profits from yest entry bc of the market weakness. I will see if will re-enter or not. The swing idea worked.
|
#CYTO
#yest
#cyto
#acinvestorblog
#worked
#weakness
|
1 month ago @James_Foresight
$SNGX nutty hold on no news, someone toying with shorts, see ya 2's at 3pm today. But until then who knows coin toss until 10am above $5/
|
#SNGX
#toying
#toss
#nutty
#sngx
#knows
|
1 month ago @InvestorsLive
$SNGX almost there .90 to go! https://t.co/EtFzXfIAtG
|
#SNGX
#sngx
#almost
#co
#SNGX
|
1 month ago @biostocks
$AUPH Q1 net revenue $34.4M
Increases FY'23 revenue guidance range to $135 - $155 million from $120 - $140 million… https://t.co/7ougfP3MWk
|
#AUPH
#million
#revenue
#auph
#increases
#range
|
1 month ago @biostocks
$AUPH Q1 EPS $(0.18) beats $(0.22) est.
Sales $34.4M beat $28.1M est.
|
#AUPH
#auph
#biostocks
#beats
#beat
#sales
|
1 month ago @semodough
RT @BioStocks: $AUPH Q1 net revenue $34.4M
Increases FY'23 revenue guidance range to $135 - $155 million from $120 - $140 million.
Cash,…
|
#AUPH
#million
#revenue
#auph
#biostocks
#semodough
|
1 month ago @biostocks
$LQDA Q1. Cash totaled $94.4M.
Continues to anticipate final legal resolution in late 2023 or 1H'24.
https://t.co/WKm0CfXbxy $UTHR
|
#LQDA
#uthrbiostocks
#totaled
#resolution
#anticipate
#lqda
|
1 month ago @FlashAlert_me
$STOK [15s. delayed] filed form 8-K on May 04, 07:05:24 https://t.co/W7bdq2UZXP
|
#STOK
#stok
#filed
#delayed
#form
#co
|
1 month ago @ACInvestorBlog
$CYTO big gap up in PM oh boy, a heavily shorted name with a very low float !!
|
#CYTO
#oh
#acinvestorblog
#cyto
#heavily
#name
|
1 month ago @semodough
$ICVX RA owns 10 percent - & evercore calling very under appreciated asset https://t.co/48uTnP2EHl
|
#ICVX
#icvx
#evercore
#appreciated
#percent
#calling
|
1 month ago @FlashAlert_me
$BMY [15s. delayed] filed SEC form 3: EVP, Chief Commercial Officer Lenkowsky Adam:
https://t.co/6leMX3EVO4
|
#BMY
#lenkowsky
#adam
#bmy
#commercial
#officer
|
1 month ago @FlashAlert_me
$BMY [15s. delayed] filed SEC form 4: SVP & Controller Greenlees Sharon:
Disposed 408 of Common Stock at average p… https://t.co/1X4x8PwBA4
|
#BMY
#sharon
#greenlees
#controller
#bmy
#disposed
|
1 month ago @FlashAlert_me
$BMY [15s. delayed] filed SEC form 4: EVP, Chief Commercial Officer Lenkowsky Adam:
Transacted Derivative Securiti… https://t.co/zsWjiIX5tG
|
#BMY
#transacted
#securiti
#derivative
#lenkowsky
#adam
|
1 month ago @semodough
$PHAT - quietly doubled off lows the last 5 weeks
|
#PHAT
#weekssemodough
#quietly
#phat
#doubled
#lows
|
1 month ago @semodough
$RARE $MREO more progress on Setrusumab https://t.co/b2eOJEgSv1 https://t.co/sjObT0ulqG https://t.co/ZDzx5KYN4Z
|
#MREO
#rare
#setrusumab
#mreo
#progress
#MREO
|
1 month ago @CatalystWatcher
$GRCL headed back above $2 as we move towards ASCO. Very under-the-radar play trading well below cash. https://t.co/aGoW1TOFT8
|
#GRCL
#headed
#asco
#towards
#radar
#grcl
|
1 month ago @ACInvestorBlog
$CYTO took a swing position for the coming days. Low float beaten down bio names are getting HOT again, so i love t… https://t.co/tlytbLv7FX
|
#CYTO
#swing
#beaten
#cyto
#names
#love
|
1 month ago @ACInvestorBlog
$CYTO another beaten down low float bio name like HCDI heavily shorted (Finviz and TD Ameritrade shows 110% short f… https://t.co/Tyn28ecbp1
|
#CYTO
#finviz
#ameritrade
#hcdi
#shows
#heavily
|
1 month ago @ACInvestorBlog
$CYTO some hits in AHs
|
#CYTO
#hits
#ahsacinvestorblog
#cyto
#CYTO
|
1 month ago @ACInvestorBlog
$CYTO heavily shorted low float bio name making new highs in AHs
|
#CYTO
#ahsacinvestorblog
#heavily
#cyto
#name
#making
|
1 month ago @TradeWithAlerts
Nice print for $BMY Size: 145879 Price: 68.74 Amount: $10,027,722.46 Time: 930
See more: https://t.co/hE7avotH4d
Jo… https://t.co/u8QRAZUSCz
|
#BMY
#jo
#print
#size
#amount
#nice
|
1 month ago @TradeWithAlerts
Nice print for $PFE Size: 311515 Price: 39.35 Amount: $12,258,115.25 Time: 930
See more: https://t.co/9Zy8l0wcC6
Jo… https://t.co/OibnitjrWV
|
#PFE
#jo
#print
#size
#amount
#nice
|
1 month ago @semodough
@BioFarmer715 @Pharmdca Solid tumor data big for $XAIR
|
#XAIR
#xairsemodough
#tumor
#pharmdca
#solid
#XAIR
|
1 month ago @semodough
RT @ej23ny: $MREO
2 important catalyst in 2nd qtr: huge upside potential
setrusumab Phase 2 data and Phase 3 transition (guided for mid…
|
#MREO
#phase
#setrusumab
#mreo
#guided
#semodough
|
1 month ago @biostocks
$AUPH Announces NICE Recommendation of LUPKYNIS For Adults with Active Lupus Nephritis
|
#AUPH
#nephritisbiostocks
#lupus
#lupkynis
#auph
#adults
|
1 month ago @FlashAlert_me
$DCPH [15s. delayed] filed form 10-Q on May 03, 07:10:05 https://t.co/9BmAkSmocs
|
#DCPH
#dcph
#filed
#form
#delayed
#co
|
1 month ago @FlashAlert_me
$DCPH [15s. delayed] filed form 8-K on May 03, 07:07:01 https://t.co/cHQjTC5imR
|
#DCPH
#dcph
#filed
#form
#delayed
#co
|
1 month ago @StockSwingAlert
$APM smoke em’ if you got ‘em
83% out the gate $6.41 200ma break to NHOD as called $11.79 ???
Back to bed before… https://t.co/41VnuTy9qL
|
#APM
#smoke
#gate
#nhod
#apm
#called
|
1 month ago @James_Foresight
May 3 7am watch: $APM $AKAN $KRBP $IMGN $DRMA $GDC $SPY $WWR https://t.co/aLdeLnZqc2
|
#APM
#krbp
#drma
#imgn
#akan
#watch
|
1 month ago @semodough
Pretty interesting comment from $PFE today on #GLP M&A https://t.co/7NPHtfeEXj
|
#PFE
#pfe
#comment
#interesting
#pretty
#today
|
1 month ago @FlashAlert_me
$GILD [15s. delayed] filed SEC form 4: Insider Lofton Kevin E:
Gifted 12,868 of Common Stock at price $0 on 2023-0… https://t.co/71I0nHT6ro
|
#GILD
#lofton
#kevin
#delayed
#insider
#common
|
1 month ago @FlashAlert_me
$ACAD [15s. delayed] filed SEC form 4: CEO DAVIS STEPHEN:
Disposed 7,806 of Common Stock at price $21.18 and Conve… https://t.co/un7ik0Ek2B
|
#ACAD
#davis
#conve
#acad
#stephen
#disposed
|
1 month ago @FlashAlert_me
$TARS [15s. delayed] filed SEC form 4: President/CEO and Board Chair Azamian Bobak R.:
Disposed 10,119 of Common S… https://t.co/uuvAjUHj0H
|
#TARS
#tars
#bobak
#azamian
#chair
#disposed
|
1 month ago @biostocks
$ARQT Completes Enrollment in INTEGUMENT-PED Pivotal Phase 3 Trial of Roflumilast Cream for the Treatment of Atopic… https://t.co/LxZwdWNG7c
|
#ARQT
#roflumilast
#cream
#atopic
#arqt
#pivotal
|
1 month ago @semodough
GS $DAWN PT 63 couple pages defending NDA given the meeting has occurred and management still intends to move forw… https://t.co/h7sOKJgDVT
|
#DAWN
#occurred
#forw
#defending
#dawn
#intends
|
1 month ago @semodough
@ripster47 $DAWN nice #ASCO23 setup ?? ORAL presentation
|
#DAWN
#presentationsemodough
#oral
#dawn
#setup
#nice
|
1 month ago @biostocks
$INCY Q1 Adj EPS $0.37 misses $0.75 est.
Sales $808.67M miss $857.52M est.
|
#INCY
#misses
#incy
#miss
#biostocks
#sales
|
1 month ago @semodough
$INCY 3.1 billion cash - another biotech that needs to start filling in pipeline &revenue before patent cliff 2027… https://t.co/8Jf9fTpUjJ
|
#INCY
#patent
#incy
#filling
#cliff
#biotech
|
1 month ago @semodough
RT @BiopharmIQ: @Pharmdca Lots of data coming this quarter/half for $BTAI and $AXSM! https://t.co/VnIzngMlgq
|
#AXSM
#vnizngmlgqsemodough
#btai
#biopharmiq
#pharmdca
#axsm
|
1 month ago @TradeWithAlerts
Nice print for $PFE Size: 393490 Price: 39.46 Amount: $15,527,115.40 Time: 930
See more: https://t.co/9Zy8l0wcC6
Jo… https://t.co/Rueanou3Al
|
#PFE
#jo
#print
#amount
#size
#nice
|
1 month ago @johnscharts
52-Week Highs
#28 Industry: Medical-Biomed/Biotech
$ACAD, $BIIB, $BLU, $ISEE, $PRVB, $VRTX https://t.co/h9ZF2WuKIB
|
#BLU
#prvb
#biomed
#biib
#acad
#vrtx
|
1 month ago @biostocks
$PFE Q1 Adj EPS $1.23 beats $0.98 Est.
Sales $18.28B beat $16.59B Est.
Q1'23 revenues of $18.3B, a decrease of $7.… https://t.co/hMPGZW8nOH
|
#PFE
#adj
#decrease
#revenues
#beats
#beat
|
1 month ago @biostocks
$PFE sees FY'23 Comirnaty revenue ~$13.5B, down 64%. Paxlovid revenue ~$8B, down 58%.
|
#PFE
#revenue
#paxlovid
#comirnaty
#sees
#biostocks
|
1 month ago @FlashAlert_me
$PXMD [15s. delayed] filed SEC form 4/A: Director LaRochelle Karen:
Delivered securities 1,143 of Common Stock at… https://t.co/CdubCzGO8a
|
#PXMD
#pxmd
#delivered
#director
#delayed
#common
|
1 month ago @FlashAlert_me
$PXMD [15s. delayed] filed SEC form 4/A: Chief Operating Officer Rome Zachary:
Delivered securities 9,584 of Commo… https://t.co/jhlBauJeHC
|
#PXMD
#zachary
#rome
#commo
#pxmd
#delivered
|
1 month ago @wallstreetbets
What to do for Pfizer's Earnings tomorrow morning
|
#PFE
#pfizer
#vaccine
#earnings
#products
#year
|
1 month ago @biostocks
$ERAS Granted FDA Fast Track Designation for CNS-Penetrant EGFR Inhibitor ERAS-801 in Patients with Glioblastoma
|
#ERAS
#eras
#egfr
#inhibitor
#designation
#granted
|
1 month ago @semodough
$MRK $ABBV $BMY. $RXDX https://t.co/gMKrlOwxLy
|
#BMY
#rxdx
#abbv
#bmy
#BMY
|
1 month ago @biostocks
$NERV Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia.
The decis… https://t.co/Gtqgpy2hX5
|
#NERV
#symptoms
#schizophrenia
#roluperidone
#decis
#treatment
|
1 month ago @semodough
Nice recovery on $APLS after being down 6-7 bucks earlier https://t.co/KqWckGmckl
|
#APLS
#apls
#bucks
#recovery
#earlier
#nice
|
1 month ago @BreakoutStocks
Stocks taking off...Today's biggest breakouts https://t.co/G9yq48clwe $SECO $ZYXI $IMVT at 12:00pm pst
|
#IMVT
#zyxi
#seco
#pstbreakoutstocks
#imvt
#breakouts
|
1 month ago @semodough
RT @Quantumup1: H.C. Wainwright reiterated Buy/$45 $DAWN shares are down 40% YTD on misplaced investor fears of FDA approval for tovorafeni…
|
#DAWN
#tovorafeni
#dawn
#wainwright
#reiterated
#fears
|
1 month ago @semodough
$MREO $RARE moving right along $RARE earnings call May 4 https://t.co/0TaL3wh92H https://t.co/tM7LbJlmKm
|
#MREO
#rare
#along
#moving
#right
#call
|
1 month ago @biostocks
$BMEA Announces FDA Clearance of IND Application for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
|
#BMEA
#covalent
#bmea
#relapsed
#refractory
#acute
|
1 month ago @FlashAlert_me
$ONTX [15s. delayed] filed form 10-K/A on May 01, 16:32:38 https://t.co/dVcsvZN7o0
|
#ONTX
#delayed
#filed
#form
#co
#ONTX
|
1 month ago @semodough
$APLS down 6 in early trade https://t.co/SLOl8f8q14
|
#APLS
#apls
#early
#trade
#APLS
|
1 month ago @biostocks
$IMVT initiated with a Buy at BofA. PT $26
|
#IMVT
#initiated
#imvt
#bofa
#buy
#IMVT
|
1 month ago @biostocks
$ASND FDA issues CRL for TransCon PTH NDA for the treatment of adults with hypoparathyroidism
|
#ASND
#transcon
#nda
#hypoparathyroidismbiostocks
#asnd
#adults
|
1 month ago @biostocks
$FGEN Announces Non-Dilutive Term Loan Financing for up to $150 Million with Morgan Stanley Tactical Value
https://t.co/boGXyTE9kn
|
#FGEN
#tactical
#fgen
#dilutive
#loan
#stanley
|
1 month ago @biostocks
$BMY TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi in Relapsed or Refractory Follicular Lymphoma and Mantl… https://t.co/mvWBc8sHvc
|
#BMY
#transcend
#mantl
#relapsed
#refractory
#lymphoma
|
1 month ago @biostocks
$BMY FDA Accepts for Priority Review sBLA and EMA Validates Application for Reblozyl as First-Line Treatment of Ane… https://t.co/bB1DmOGEYD
|
#BMY
#sbla
#validates
#reblozyl
#priority
#accepts
|
1 month ago @semodough
$VKTX - very important nugget on VK2809 as we await data - it’s significantly more potent then $MDGL… https://t.co/OOkq7k71dT
|
#MDGL
#mdgl
#nugget
#await
#potent
#vktx
|
1 month ago @options
25% Returns selling covered calls? This can't be legit. What am I missing?
|
#JAN
#covered
#dividend
#missing
#yield
#producing
|
1 month ago @semodough
RT @mtheory11bio: $MREO setrusumab could be a blockbuster in osteogenesis imperfecta (OI).
Based on Cantor projections of their agreement…
|
#MREO
#setrusumab
#osteogenesis
#mreo
#imperfecta
#projections
|
1 month ago @SqueezeFinder
@KEISUKEA16 $CYTO is currently at 63% Squeezability. You can easily check my scores on any ticker here:
https://t.co/iVkVzaXbf8
|
#CYTO
#squeezability
#cyto
#easily
#scores
#check
|
1 month ago @semodough
RT @TomSilver39: Jefferies: Kidney Meetings (ERA-EDTA & EULAR 6/15- 6/18) $AUPH Titles: ..." SVB:" $AUPH Launch Tracking Well; trends as en…
|
#AUPH
#auph
#kidney
#eular
#titles
#meetings
|
1 month ago @CatalystWatcher
Went long $GRCL for ASCO. Company is crazy cheap and has amazing data in R/R MM. Company trades well below cash an… https://t.co/xpaQxbZKIU
|
#GRCL
#xpaqxbzkiucatalystwatcher
#asco
#grcl
#crazy
#amazing
|
1 month ago @CatalystWatcher
$GRCL Orbimed been loading the boat here. https://t.co/CBtGHCKqUh
|
#GRCL
#cbtghckquhcatalystwatcher
#boat
#orbimed
#grcl
#loading
|
1 month ago @CatalystWatcher
Interestingly, Orbimed is an activist investor in $GRCL and filed a 13D back in March.
https://t.co/5XTnNIycNF
|
#GRCL
#activist
#orbimed
#interestingly
#grcl
#investor
|
1 month ago @stocks
(4/27) Thursday's Pre-Market Stock Movers & News
|
#BMY
#click
#chart
#imgur
#finviz
#BMY
|
1 month ago @FlashAlert_me
$RDHL [15s. delayed] filed form 6-K on April 28, 07:07:02 https://t.co/aqnao48GVl
|
#RDHL
#rdhl
#delayed
#filed
#form
#april
|
1 month ago @FlashAlert_me
$RDHL [15s. delayed] filed form 20-F on April 28, 07:07:29 https://t.co/svCeSXqtER
|
#RDHL
#svcesxqterflashalert_me
#rdhl
#delayed
#filed
#form
|
1 month ago @FlashAlert_me
$MORF [15s. delayed] filed SEC form 4: President Rogers Bruce:
Disposed 30,000 of Common Stock at price $53.4 and… https://t.co/ceCr7UrmGk
|
#MORF
#rogers
#bruce
#morf
#disposed
#president
|
1 month ago @FlashAlert_me
$MORF [15s. delayed] filed SEC form 4: CFO and COO SCHEGERIN MARC:
Disposed 50,000 of Common Stock at price $54.71… https://t.co/08d4zwCh6g
|
#MORF
#schegerin
#marc
#morf
#disposed
#form
|
1 month ago @FlashAlert_me
$MORF [15s. delayed] filed SEC form 4: President and CEO Tipirneni Praveen P.:
Disposed 25,179 of Common Stock at… https://t.co/w2GHIgWyWW
|
#MORF
#tipirneni
#praveen
#morf
#disposed
#president
|
1 month ago @FlashAlert_me
$MORF [15s. delayed] filed SEC form 4: SVP Finance and CAO Farrell Robert E Jr:
Disposed 10,000 of Common Stock at… https://t.co/lKVi9PYlv0
|
#MORF
#farrell
#robert
#svp
#morf
#disposed
|
1 month ago @semodough
RT @LifeSciFocus: $PTGX HCW: https://t.co/Ya3e8KNUQt
|
#PTGX
#ptgx
#lifescifocus
|